BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Botterweck AA, Schouten LJ, Volovics A, Dorant E, van Den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 2000;29:645-54. [PMID: 10922340 DOI: 10.1093/ije/29.4.645] [Cited by in Crossref: 376] [Cited by in F6Publishing: 375] [Article Influence: 17.1] [Reference Citation Analysis]
Number Citing Articles
1 Sabbagh LC. Esophageal cancer. Gastrointest Endosc 2009;69:S93-6. [PMID: 19179181 DOI: 10.1016/j.gie.2008.12.009] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Kawano A, Nakajima TE, Oda I, Hokamura N, Iwasa S, Kato K, Hamaguchi T, Yamada Y, Fujii H, Shimada Y. Comparison of advanced adenocarcinomas of esophagogastric junction and distal stomach in Japanese patients. Gastric Cancer 2014;17:54-60. [DOI: 10.1007/s10120-013-0238-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Yang S, Wu S, Huang Y, Shao Y, Chen XY, Xian L, Zheng J, Wen Y, Chen X, Li H, Yang C. Screening for oesophageal cancer. Cochrane Database Syst Rev 2012;12:CD007883. [PMID: 23235651 DOI: 10.1002/14651858.CD007883.pub2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
4 Ip B, Ng KT, Packer S, Paterson-Brown S, Couper GW. High serum lactate as an adjunct in the early prediction of anastomotic leak following oesophagectomy. Int J Surg 2017;46:7-10. [PMID: 28803998 DOI: 10.1016/j.ijsu.2017.08.027] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
5 Schizas D, Frountzas M, Sgouromallis E, Spartalis E, Mylonas KS, Papaioannou TG, Dimitroulis D, Nikiteas N. Esophageal defect repair by artificial scaffolds: a systematic review of experimental studies and proportional meta-analysis. Dis Esophagus 2021;34:doaa104. [PMID: 33016317 DOI: 10.1093/dote/doaa104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Yates M, Cheong E, Luben R, Igali L, Fitzgerald R, Khaw KT, Hart A. Body mass index, smoking, and alcohol and risks of Barrett’s esophagus and esophageal adenocarcinoma: a UK prospective cohort study. Dig Dis Sci. 2014;59:1552-1559. [PMID: 24500448 DOI: 10.1007/s10620-013-3024-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
7 Lagarde SM, de Boer JD, ten Kate FJW, Busch ORC, Obertop H, van Lanschot JJB. Postoperative Complications After Esophagectomy for Adenocarcinoma of the Esophagus Are Related to Timing of Death Due to Recurrence. Annals of Surgery 2008;247:71-6. [DOI: 10.1097/sla.0b013e31815b695e] [Cited by in Crossref: 101] [Cited by in F6Publishing: 31] [Article Influence: 7.2] [Reference Citation Analysis]
8 Weiderpass E, Pukkala E. Time trends in socioeconomic differences in incidence rates of cancers of gastro-intestinal tract in Finland. BMC Gastroenterol 2006;6:41. [PMID: 17144908 DOI: 10.1186/1471-230X-6-41] [Cited by in Crossref: 61] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
9 Suh YS, Han DS, Kong SH, Lee HJ, Kim YT, Kim WH, Lee KU, Yang HK. Should adenocarcinoma of the esophagogastric junction be classified as esophageal cancer? A comparative analysis according to the seventh AJCC TNM classification. Ann Surg. 2012;255:908-915. [PMID: 22504190 DOI: 10.1097/sla.0b013e31824beb95] [Cited by in Crossref: 68] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]
10 Kim HJ, Kim N, Kim HY, Lee HS, Yoon H, Shin CM, Park YS, Park DJ, Kim HH, Lee KH. Relationship between body mass index and the risk of early gastric cancer and dysplasia regardless of Helicobacter pylori infection. Gastric Cancer. 2014;Epub ahead of print. [PMID: 25240409 DOI: 10.1007/s10120-014-0429-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
11 Lee YY, McColl KE. Disruption of the gastroesophageal junction by central obesity and waist belt: role of raised intra-abdominal pressure. Dis Esophagus. 2015;28:318-325. [PMID: 24575877 DOI: 10.1111/dote.12202] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
12 Bose K, Franck C, Müller MN, Canbay A, Link A, Venerito M. Perioperative Therapy of Oesophagogastric Adenocarcinoma: Mainstay and Future Directions. Gastroenterol Res Pract 2017;2017:5651903. [PMID: 28785280 DOI: 10.1155/2017/5651903] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
13 Akiyama T, Inamori M, Akimoto K, Iida H, Mawatari H, Endo H, Ikeda T, Nozaki Y, Yoneda K, Sakamoto Y. Risk factors for the progression of endoscopic Barrett’s epithelium in Japan: a multivariate analysis based on the Prague C & amp; M Criteria. Dig Dis Sci. 2009;54:1702-1707. [PMID: 19003532 DOI: 10.1007/s10620-008-0537-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
14 Leers JM, Knepper L, van der Veen A, Schröder W, Fuchs H, Schiller P, Hellmich M, Zettelmeyer U, Brosens LAA, Quaas A, Ruurda JP, van Hillegersberg R, Bruns CJ. The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II. BMC Cancer 2020;20:781. [PMID: 32819399 DOI: 10.1186/s12885-020-07152-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Balbuena L, Casson AG. Physical activity, obesity and risk for esophageal adenocarcinoma. Future Oncology 2009;5:1051-63. [DOI: 10.2217/fon.09.65] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
16 Beales IL, Vardi I, Dearman L, Broughton T. Statin use is associated with a reduction in the incidence of esophageal adenocarcinoma: a case control study. Dis Esophagus. 2012;Sep 18; Epub ahead of print. [PMID: 22989236 DOI: 10.1111/j.1442-2050.2012.01412.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
17 DeMeester SR. Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment. Ann Surg Oncol. 2006;13:12-30. [PMID: 16378161 DOI: 10.1245/aso.2005.12.025] [Cited by in Crossref: 152] [Cited by in F6Publishing: 56] [Article Influence: 9.5] [Reference Citation Analysis]
18 McColl KE. Cancer of the gastric cardia. Best Pract Res Clin Gastroenterol. 2006;20:687-696. [PMID: 16997153 DOI: 10.1016/j.bpg.2006.03.005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
19 Vereczkei A, Horvath OP, Varga G, Molnar TF. Gastroesophageal reflux disease and non-small cell lung cancer. Results of a pilot study. Dis Esophagus. 2008;21:457-460. [PMID: 19125801 DOI: 10.1111/j.1442-2050.2007.00796.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
20 Park S, Mok Y, Kim J, Park S, Kim S, Kim C. Clinical significance of gastric outlet obstruction on the oncologic and surgical outcomes of radical surgery for carcinoma of the distal stomach: Gastric Cancer With Outlet Obstruction. J Surg Oncol 2009;100:215-21. [DOI: 10.1002/jso.21256] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
21 Conio M, Filiberti R, Blanchi S, Ferraris R, Marchi S, Ravelli P, Lapertosa G, Iaquinto G, Sablich R, Gusmaroli R. Risk factors for Barrett’s esophagus: a case-control study. Int J Cancer. 2002;97:225-229. [PMID: 11774268 DOI: 10.1002/ijc.1583] [Cited by in Crossref: 112] [Cited by in F6Publishing: 101] [Article Influence: 5.6] [Reference Citation Analysis]
22 Zhu Z, Gong YB, Xu HM. Neoadjuvant therapy strategies for advanced gastric cancer: Current innovations and future challenges. Chronic Dis Transl Med 2020;6:147-57. [PMID: 32908968 DOI: 10.1016/j.cdtm.2020.03.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
23 Hagens ERC, Anderegg MCJ, van Berge Henegouwen MI, Gisbertz SS. International Survey on the Management of Anastomotic Leakage After Esophageal Resection. Ann Thorac Surg 2018;106:1702-8. [PMID: 29883644 DOI: 10.1016/j.athoracsur.2018.05.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
24 Steevens J, Botterweck AA, Dirx MJ, van den Brandt PA, Schouten LJ. Trends in incidence of oesophageal and stomach cancer subtypes in Europe. Eur J Gastroenterol Hepatol. 2010;22:669-678. [PMID: 19474750 DOI: 10.1097/meg.0b013e32832ca091] [Cited by in Crossref: 21] [Cited by in F6Publishing: 62] [Article Influence: 1.8] [Reference Citation Analysis]
25 Chen H, Wang LD, Guo M, Gao SG, Guo HQ, Fan ZM, Li JL. Alterations of p53 and PCNA in cancer and adjacent tissues from concurrent carcinomas of the esophagus and gastric cardia in the same patient in Linzhou, a high incidence area for esophageal cancer in northern China. World J Gastroenterol 2003; 9(1): 16-21 [PMID: 12508343 DOI: 10.3748/wjg.v9.i1.16] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
26 Casson AG, Schrump DS. BIOLOGY AND EPIDEMIOLOGY OF MALIGNANT ESOPHAGEAL CARCINOMA. Pearson's Thoracic and Esophageal Surgery. Elsevier; 2008. pp. 439-53. [DOI: 10.1016/b978-0-443-06861-4.50191-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Lee JH, Lee HJ, Choi YS, Kim TH, Huh YJ, Suh YS, Kong SH, Yang HK. Postoperative Quality of Life after Total Gastrectomy Compared with Partial Gastrectomy: Longitudinal Evaluation by European Organization for Research and Treatment of Cancer-OG25 and STO22. J Gastric Cancer 2016;16:230-9. [PMID: 28053809 DOI: 10.5230/jgc.2016.16.4.230] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
28 Jiang Y, Chen Y, Chen T, Wu L, Ou J, Li R, Zhang X, Yang J, Cao J. Is there association of gross tumor volume of adenocarcinoma of oesophagogastric junction measured on magnetic resonance imaging with N stage? European Journal of Radiology 2019;110:181-6. [DOI: 10.1016/j.ejrad.2018.05.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
29 Gerson LB, Triadafilopoulos G. Screening for esophageal adenocarcinoma. The American Journal of Medicine 2002;113:499-505. [DOI: 10.1016/s0002-9343(02)01234-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
30 Kelly P, Appleyard V, Murray K, Paulin F, Lamont D, Baker L, Suttie S, Exon D, Thompson A. Detection of oesophageal cancer biomarkers by plasma proteomic profiling of human cell line xenografts in response to chemotherapy. Br J Cancer. 2010;103:232-238. [PMID: 20551956 DOI: 10.1038/sj.bjc.6605741] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
31 Tornesello ML, Monaco R, Nappi O, Buonaguro L, Buonaguro FM. Detection of mucosal and cutaneous human papillomaviruses in oesophagitis, squamous cell carcinoma and adenocarcinoma of the oesophagus. Journal of Clinical Virology 2009;45:28-33. [DOI: 10.1016/j.jcv.2009.02.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
32 Antonowicz SS, Lorenzi B, Parker M, Tang CB, Harvey M, Kadirkamanathan SS. Annual computed tomography scans do not improve outcomes following esophagectomy for cancer: a 10-year UK experience. Dis Esophagus 2015;28:365-70. [PMID: 24649807 DOI: 10.1111/dote.12209] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
33 Gajperia C, Barbiere JM, Greenberg D, Wright K, Lyratzopoulos G. Recent incidence trends and sociodemographic features of oesophageal and gastric cancer types in an English region. Alimentary Pharmacology & Therapeutics 2009;30:873-80. [DOI: 10.1111/j.1365-2036.2009.04100.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
34 Melhado RE, Alderson D, Tucker O. The changing face of esophageal cancer. Cancers (Basel). 2010;2:1379-1404. [PMID: 24281163 DOI: 10.3390/cancers2031379] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
35 Lin R, Xiao D, Guo Y, Tian D, Yun H, Chen D, Su M. Chronic inflammation-related DNA damage response: a driving force of gastric cardia carcinogenesis. Oncotarget 2015;6:2856-64. [PMID: 25650663 DOI: 10.18632/oncotarget.3091] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
36 Pera M, Manterola C, Vidal O, Grande L. Epidemiology of esophageal adenocarcinoma. J Surg Oncol. 2005;92:151-159. [PMID: 16299786 DOI: 10.1002/jso.20357] [Cited by in Crossref: 216] [Cited by in F6Publishing: 189] [Article Influence: 12.7] [Reference Citation Analysis]
37 Kamangar F, Chow WH, Abnet CC, Dawsey SM. Environmental causes of esophageal cancer. Gastroenterol Clin North Am. 2009;38:27-57, vii. [PMID: 19327566 DOI: 10.1016/j.gtc.2009.01.004] [Cited by in Crossref: 222] [Cited by in F6Publishing: 319] [Article Influence: 17.1] [Reference Citation Analysis]
38 Kendall BJ, Whiteman DC. Temporal Changes in the Endoscopic Frequency of New Cases of Barrett's Esophagus in an Australian Health Region. Am J Gastroenterol 2006;101:1178-82. [DOI: 10.1111/j.1572-0241.2006.00548.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.0] [Reference Citation Analysis]
39 Alidina A, Gaffar A, Hussain F, Islam M, Vaziri I, Burney I, Valimohd A, Jafri W. Survival data and prognostic factors seen in Pakistani patients with esophageal cancer. Ann Oncol 2004;15:118-22. [PMID: 14679130 DOI: 10.1093/annonc/mdh014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
40 Koppert LB, van der Velden AW, van de Wetering M, Abbou M, van den Ouweland AM, Tilanus HW, Wijnhoven BP, Dinjens WN. Frequent loss of the AXIN1 locus but absence of AXIN1 gene mutations in adenocarcinomas of the gastro-oesophageal junction with nuclear beta-catenin expression. Br J Cancer 2004;90:892-9. [PMID: 14970870 DOI: 10.1038/sj.bjc.6601589] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
41 Wang X, Liu F, Li Y, Tang S, Zhang Y, Chen Y, Khan SA. Comparison on Clinicopathological Features, Treatments and Prognosis between Proximal Gastric Cancer and Distal Gastric Cancer: A National Cancer Data Base Analysis. J Cancer 2019;10:3145-53. [PMID: 31289585 DOI: 10.7150/jca.30371] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
42 Combet E, Paterson S, Iijima K, Winter J, Mullen W, Crozier A, Preston T, McColl KE. Fat transforms ascorbic acid from inhibiting to promoting acid-catalysed N-nitrosation. Gut 2007;56:1678-84. [PMID: 17785370 DOI: 10.1136/gut.2007.128587] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
43 Wang Y, McManus DT, Arthur K, Johnston BT, Kennedy AJ, Coleman HG, Murray LJ, Hamilton PW. Whole slide image cytometry: a novel method to detect abnormal DNA content in Barrett's esophagus. Lab Invest. 2015;95:1319-1330. [PMID: 26237272 DOI: 10.1038/labinvest.2015.98] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
44 van Straten D, Mashayekhi V, de Bruijn HS, Oliveira S, Robinson DJ. Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions. Cancers (Basel) 2017;9:E19. [PMID: 28218708 DOI: 10.3390/cancers9020019] [Cited by in Crossref: 355] [Cited by in F6Publishing: 295] [Article Influence: 71.0] [Reference Citation Analysis]
45 Richter JE, Kahrilas PJ, Sontag SJ, Kovacs TO, Huang B, Pencyla JL. Comparing lansoprazole and omeprazole in onset of heartburn relief: results of a randomized, controlled trial in erosive esophagitis patients. Am J Gastroenterol. 2001;96:3089-3098. [PMID: 11721754 DOI: 10.1111/j.1572-0241.2001.05263.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
46 Casson AG, Zheng Z, Evans SC, Veugelers PJ, Porter GA, Guernsey DL. Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma. Carcinogenesis 2005;26:1536-41. [PMID: 15878910 DOI: 10.1093/carcin/bgi115] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 3.7] [Reference Citation Analysis]
47 Wijnhoven BP, Louwman MW, Tilanus HW, Coebergh JW. Increased incidence of adenocarci-nomas at the gastro-oesophageal junction in Dutch males since the 1990s. Eur J Gastroenterol Hepatol. 2002;14:115-122. [PMID: 11981334 DOI: 10.1097/00042737-200202000-00004] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 2.2] [Reference Citation Analysis]
48 Hong Y, Chen H, Rao Z, Peng B, Hu H, Lin S, Xu Z. In vitro study on the role of SOX9 in trastuzumab resistance of adenocarcinoma of the esophagogastric junction. Exp Ther Med 2018;15:3103-7. [PMID: 29456713 DOI: 10.3892/etm.2018.5744] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Goéré D, Gras-Chaput N, Aupérin A, Flament C, Mariette C, Glehen O, Zitvogel L, Elias D. Treatment of gastric peritoneal carcinomatosis by combining complete surgical resection of lesions and intraperitoneal immunotherapy using catumaxomab. BMC Cancer 2014;14:148. [PMID: 24589307 DOI: 10.1186/1471-2407-14-148] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
50 Lynge E, Andersen A, Rylander L, Tinnerberg H, Lindbohm ML, Pukkala E, Romundstad P, Jensen P, Clausen LB, Johansen K. Cancer in persons working in dry cleaning in the Nordic countries. Environ Health Perspect 2006;114:213-9. [PMID: 16451857 DOI: 10.1289/ehp.8425] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
51 Ang TL, Fock KM. Clinical epidemiology of gastric cancer. Singapore Med J. 2014;55:621-628. [PMID: 25630323 DOI: 10.11622/smedj.2014174] [Cited by in Crossref: 152] [Cited by in F6Publishing: 149] [Article Influence: 21.7] [Reference Citation Analysis]
52 Tamaki T, Dong Y, Ohno Y, Sobue T, Nishimoto H, Shibata A. The burden of rare cancer in Japan: application of the RARECARE definition. Cancer Epidemiol 2014;38:490-5. [PMID: 25155209 DOI: 10.1016/j.canep.2014.07.014] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
53 Miccio JA, Oladeru OT, Yang J, Xue Y, Choi M, Zhang Y, Yoon H, Ryu S, Stessin AM. Neoadjuvant vs. adjuvant treatment of Siewert type II gastroesophageal junction cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry. J Gastrointest Oncol 2016;7:403-10. [PMID: 27284473 DOI: 10.21037/jgo.2015.10.06] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
54 Zhu Z, Friess H, Kleeff J, Wang L, Wirtz M, Zimmermann A, Korc M, Büchler MW. Glypican-3 expression is markedly decreased in human gastric cancer but not in esophageal cancer. Am J Surg 2002;184:78-83. [PMID: 12135726 DOI: 10.1016/s0002-9610(02)00884-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
55 Derakhshan MH, Yazdanbod A, Sadjadi AR, Shokoohi B, McColl KE, Malekzadeh R. High incidence of adenocarcinoma arising from the right side of the gastric cardia in NW Iran. Gut 2004;53:1262-6. [PMID: 15306582 DOI: 10.1136/gut.2003.035857] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
56 Schweigert M, Dubecz A, Stein HJ. Oesophageal cancer--an overview. Nat Rev Gastroenterol Hepatol. 2013;10:230-244. [PMID: 23296250 DOI: 10.1038/nrgastro.2012.236] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 5.8] [Reference Citation Analysis]
57 Homs MY, Steyerberg EW, Eijkenboom WM, Tilanus HW, Stalpers LJ, Bartelsman JF, van Lanschot JJ, Wijrdeman HK, Mulder CJ, Reinders JG, Boot H, Aleman BM, Kuipers EJ, Siersema PD. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. The Lancet 2004;364:1497-504. [DOI: 10.1016/s0140-6736(04)17272-3] [Cited by in Crossref: 332] [Cited by in F6Publishing: 66] [Article Influence: 18.4] [Reference Citation Analysis]
58 Akiyama T, Inamori M, Iida H, Endo H, Hosono K, Sakamoto Y, Fujita K, Yoneda M, Takahashi H, Koide T, Tokoro C, Goto A, Abe Y, Shimamura T, Kobayashi N, Kubota K, Saito S, Nakajima A. Shape of Barrett’s epithelium is associated with prevalence of erosive esophagitis. World J Gastroenterol 2010; 16(4): 484-489 [PMID: 20101776 DOI: 10.3748/wjg.v16.i4.484] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
59 Cordin J, Lehmann K, Schneider PM. Clinical Staging of Adenocarcinoma of the Esophagogastric Junction. In: Schneider PM, editor. Adenocarcinoma of the Esophagogastric Junction. Berlin: Springer Berlin Heidelberg; 2010. pp. 73-83. [DOI: 10.1007/978-3-540-70579-6_6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
60 Kim YJ, Chung WC, Cho IH, Kim J, Kim S. Prognostic effect of different etiologies in patients with gastric cardia cancer. Medicine (Baltimore) 2019;98:e18397. [PMID: 31852158 DOI: 10.1097/MD.0000000000018397] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
61 Gujral DM, Hawkins MA, Leonulli BG, Ashley S, Chau I, Cunningham D, Tait D. Nonsurgical Management of Esophageal Adenocarcinoma. Clinical Colorectal Cancer 2011;10:165-70. [DOI: 10.1016/j.clcc.2011.03.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
62 Kawano T, Ogiya K, Nakajima Y, Nishikage T, Nagai K. Prevalence of Barrett's esophagus in Japan. Esophagus 2006;3:155-64. [DOI: 10.1007/s10388-006-0095-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
63 Lagarde SM, Reitsma JB, ten Kate FJW, Busch ORC, Obertop H, Zwinderman AH, Moons J, van Lanschot JJB, Lerut T. Predicting Individual Survival After Potentially Curative Esophagectomy for Adenocarcinoma of the Esophagus or Gastroesophageal Junction. Annals of Surgery 2008;248:1006-13. [DOI: 10.1097/sla.0b013e318190a0a2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
64 Xiong J, Kang W, Ma F, Liu H, Ma S, Li Y, Jin P, Hu H, Tian Y. Modified Systemic Inflammation Score Is an Independent Predictor of Long-Term Outcome in Patients Undergoing Surgery for Adenocarcinoma of the Esophagogastric Junction. Front Surg 2021;8:622821. [PMID: 34820414 DOI: 10.3389/fsurg.2021.622821] [Reference Citation Analysis]
65 Sharp L, Carsin AE, Cantwell MM, Anderson LA, Murray LJ; FINBAR Study Group. Intakes of dietary folate and other B vitamins are associated with risks of esophageal adenocarcinoma, Barrett's esophagus, and reflux esophagitis. J Nutr 2013;143:1966-73. [PMID: 24132576 DOI: 10.3945/jn.113.174664] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
66 Halland M, Katzka D, Iyer PG. Recent developments in pathogenesis, diagnosis and therapy of Barrett's esophagus. World J Gastroenterol 2015; 21(21): 6479-6490 [PMID: 26074687 DOI: 10.3748/wjg.v21.i21.6479] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
67 Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97:142-146. [PMID: 15657344 DOI: 10.1093/jnci/dji024] [Cited by in Crossref: 913] [Cited by in F6Publishing: 836] [Article Influence: 53.7] [Reference Citation Analysis]
68 Haas SL, Ye W, Löhr JM. Alcohol consumption and digestive tract cancer. Curr Opin Clin Nutr Metab Care. 2012;15:457-467. [PMID: 22797570 DOI: 10.1097/mco.0b013e3283566699] [Cited by in Crossref: 43] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
69 van Blankenstein M, Looman CW, Hop WC, Bytzer P. The incidence of adenocarcinoma and squam-ous cell carcinoma of the esophagus: Barrett's esopha-gus makes a difference. Am J Gastroenterol. 2005;100:766-774. [PMID: 15784017 DOI: 10.1111/j.1572-0241.2005.40790.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
70 González CA, Pera G, Agudo A, Palli D, Krogh V, Vineis P, Tumino R, Panico S, Berglund G, Simán H, Nyrén O, Agren A, Martinez C, Dorronsoro M, Barricarte A, Tormo MJ, Quiros JR, Allen N, Bingham S, Day N, Miller A, Nagel G, Boeing H, Overvad K, Tjonneland A, Bueno-de-mesquita HB, Boshuizen HC, Peeters P, Numans M, Clavel-chapelon F, Helen I, Agapitos E, Lund E, Fahey M, Saracci R, Kaaks R, Riboli E. Smoking and the risk of gastric cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC): Smoking and Gastric Cancer Risk. Int J Cancer 2003;107:629-34. [DOI: 10.1002/ijc.11426] [Cited by in Crossref: 154] [Cited by in F6Publishing: 135] [Article Influence: 8.1] [Reference Citation Analysis]
71 Thrift AP, Kramer JR, Qureshi Z, Richardson PA, El-Serag HB. Age at onset of GERD symptoms predicts risk of Barrett's esophagus. Am J Gastroenterol 2013;108:915-22. [PMID: 23567358 DOI: 10.1038/ajg.2013.72] [Cited by in Crossref: 72] [Cited by in F6Publishing: 55] [Article Influence: 8.0] [Reference Citation Analysis]
72 Dong LM, Kristal AR, Peters U, Schenk JM, Sanchez CA, Rabinovitch PS, Blount PL, Odze RD, Ayub K, Reid BJ. Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective study. Nutr Cancer. 2008;60:39-48. [PMID: 18444134 DOI: 10.1080/01635580701586762] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
73 Nørsett KG, Laegreid A, Midelfart H, Yadetie F, Erlandsen SE, Falkmer S, Grønbech JE, Waldum HL, Komorowski J, Sandvik AK. Gene expression based classification of gastric carcinoma. Cancer Lett. 2004;210:227-237. [PMID: 15183539 DOI: 10.1016/j.canlet.2004.01.022] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
74 Fernandes ML, Seow A, Chan YH, Ho KY. Opposing trends in incidence of esophageal squamous cell carcinoma and adenocarcinoma in a multi-ethnic Asian country. Am J Gastroenterol. 2006;101:1430-1436. [PMID: 16863543 DOI: 10.1111/j.1572-0241.2006.00570.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 53] [Article Influence: 3.9] [Reference Citation Analysis]
75 Lyratzopoulos G, Barbiere JM, Gajperia C, Rhodes M, Greenberg DC, Wright KA. Trends and variation in the management of oesophagogastric cancer patients: a population-based survey. BMC Health Serv Res 2009;9:231. [PMID: 20003488 DOI: 10.1186/1472-6963-9-231] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
76 Uddin AN, Burns FJ, Rossman TG, Chen H, Kluz T, Costa M. Dietary chromium and nickel enhance UV-carcinogenesis in skin of hairless mice. Toxicology and Applied Pharmacology 2007;221:329-38. [DOI: 10.1016/j.taap.2007.03.030] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 3.1] [Reference Citation Analysis]
77 Dassen AE, Lemmens VE, van de Poll-Franse LV, Creemers GJ, Brenninkmeijer SJ, Lips DJ, Vd Wurff AA, Bosscha K, Coebergh JW. Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. Eur J Cancer. 2010;46:1101-1110. [PMID: 20219351 DOI: 10.1016/j.ejca.2010.02.013] [Cited by in Crossref: 98] [Cited by in F6Publishing: 89] [Article Influence: 8.2] [Reference Citation Analysis]
78 Satolli MA, Buffoni L, Spadi R, Roato I. Gastric cancer: The times they are a-changin’. World J Gastrointest Oncol 2015; 7(11): 303-316 [PMID: 26600930 DOI: 10.4251/wjgo.v7.i11.303] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
79 de Martel C, Forman D, Plummer M. Gastric cancer: epidemiology and risk factors. Gastroenterol Clin North Am. 2013;42:219-240. [PMID: 23639638 DOI: 10.1016/j.gtc.2013.01.003] [Cited by in Crossref: 224] [Cited by in F6Publishing: 212] [Article Influence: 24.9] [Reference Citation Analysis]
80 Kumar S, Mantero A, Delgado C, Dominguez B, Nuchovich N, Goldberg DS. Eastern European and Asian-born populations are prone to gastric cancer: an epidemiologic analysis of foreign-born populations and gastric cancer. Ann Gastroenterol 2021;34:669-74. [PMID: 34475737 DOI: 10.20524/aog.2021.0640] [Reference Citation Analysis]
81 Hawk ET, Viner JL. Statins in esophageal cancer cell lines: promising lead? Am J Gastroenterol. 2008;103:838-841. [PMID: 18371147 DOI: 10.1111/j.1572-0241.2007.01768.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
82 Savarino E, de Bortoli N, De Cassan C, Della Coletta M, Bartolo O, Furnari M, Ottonello A, Marabotto E, Bodini G, Savarino V. The natural history of gastro-esophageal reflux disease: a comprehensive review. Dis Esophagus. 2017;30:1-9. [PMID: 27862680 DOI: 10.1111/dote.12511] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
83 Schuhmacher C, Reim D, Novotny A. Neoadjuvant treatment for gastric cancer. J. Gastric Cancer. 2013;13:73-78. [PMID: 23844320 DOI: 10.5230/jgc.2013.13.2.73] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
84 Lagarde SM, ten Kate FJ, Reitsma JB, Busch OR, van Lanschot JJ. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol. 2006;24:4347-4355. [PMID: 16963732 DOI: 10.1200/jco.2005.04.9445] [Cited by in Crossref: 91] [Cited by in F6Publishing: 43] [Article Influence: 5.7] [Reference Citation Analysis]
85 Oze I, Matsuo K, Ito H, Wakai K, Nagata C, Mizoue T, Tanaka K, Tsuji I, Tamakoshi A, Sasazuki S. Cigarette smoking and esophageal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol. 2012;42:63-73. [PMID: 22131340 DOI: 10.1093/jjco/hyr170] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
86 Lambert R. Barrett's oesophagus: better left alone?: . European Journal of Gastroenterology & Hepatology 2001;13:627-30. [DOI: 10.1097/00042737-200106000-00002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
87 Polinder S, Homs MY, Siersema PD, Steyerberg EW; Dutch SIREC Study Group. Cost study of metal stent placement vs single-dose brachytherapy in the palliative treatment of oesophageal cancer. Br J Cancer 2004;90:2067-72. [PMID: 15150566 DOI: 10.1038/sj.bjc.6601815] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
88 Fontana MG, La Pinta M, Moneghini D, Villanacci V, Donato F, Rindi G, Paparini S, Baronchelli C, Bertoli G, Alquati P. Prognostic value of Goseki histological classification in adenocarcinoma of the cardia. Br J Cancer. 2003;88:401-405. [PMID: 12569383 DOI: 10.1038/sj.bjc.6600663] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
89 Schirren R, Reim D, Novotny AR. Adjuvant and/or neoadjuvant therapy for gastric cancer? A perspective review. Ther Adv Med Oncol. 2015;7:39-48. [PMID: 25553082 DOI: 10.1177/1758834014558839] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
90 Han YJ, Li J, Huang W, Fang Y, Xiao LN, Liao ZE. Fish consumption and risk of esophageal cancer and its subtypes: a systematic review and meta-analysis of observational studies. Eur J Clin Nutr 2013;67:147-54. [PMID: 23321574 DOI: 10.1038/ejcn.2012.213] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
91 Jiang L, Yang K, Guan Q, Chen Y, Zhao P, Tian J. Survival Benefit of Neoadjuvant Chemotherapy for Resectable Cancer of the Gastric and Gastroesophageal Junction: A Meta-Analysis. Journal of Clinical Gastroenterology 2015;49:387-94. [DOI: 10.1097/mcg.0000000000000212] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
92 Wang C, Song DJ, Xu ZL, Xie SP, Hu JH. A network meta-analysis of the short-term efficacy of five chemotherapy regimens based on cisplatin and fluorouracil for esophagogastric junctional adenocarcinoma. Exp Mol Med 2017;49:e383. [PMID: 28960212 DOI: 10.1038/emm.2017.170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
93 Levi F, Randimbison L, Lucchini F, Te V, La Vecchia C. Epidemiology of adenocarcinoma and squamous cell carcinoma of the oesophagus: . European Journal of Cancer Prevention 2001;10:91-6. [DOI: 10.1097/00008469-200102000-00011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
94 Smithers BM, Fahey PP, Corish T, Gotley DC, Falk GL, Smith GS, Kiroff GK, Clouston AD, Watson DI, Whiteman DC. Symptoms, investigations and management of patients with cancer of the oesophagus and gastro‐oesophageal junction in Australia. Medical Journal of Australia 2010;193:572-7. [DOI: 10.5694/j.1326-5377.2010.tb04064.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
95 Kutup A, Yekebas EF, Izbicki JR. Current diagnosis and future impact of micrometastases for therapeutic strategies in adenocarcinoma of the esophagus, gastric cardia, and upper gastric third. Recent Results Cancer Res 2010;182:115-25. [PMID: 20676876 DOI: 10.1007/978-3-540-70579-6_10] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
96 Jansson C, Jeding K, Lagergren J. Job strain and risk of esophageal and cardia cancers. Cancer Epidemiol. 2009;33:473-475. [PMID: 19926547 DOI: 10.1016/j.canep.2009.10.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
97 Crocetti E, Miccinesi G, Paci E. Decreasing incidence of all histological subtypes of oesophagus cancer in Tuscany, Italy: . European Journal of Cancer Prevention 2001;10:379-80. [DOI: 10.1097/00008469-200108000-00013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
98 Zhang CD, Takeshima H, Sekine S, Yamashita S, Liu YY, Hattori N, Abe H, Yamashita H, Fukuda M, Imamura Y, Ushiku T, Katai H, Makino H, Watanabe M, Seto Y, Ushijima T. Prediction of tissue origin of adenocarcinomas in the esophagogastric junction by DNA methylation. Gastric Cancer 2021. [PMID: 34557982 DOI: 10.1007/s10120-021-01252-y] [Reference Citation Analysis]
99 Heye T, Kuntz C, Düx M, Encke J, Palmowski M, Autschbach F, Volke F, Kauffmann GW, Grenacher L. New coil concept for endoluminal MR imaging: initial results in staging of gastric carcinoma in correlation with histopathology. Eur Radiol 2006;16:2401-9. [PMID: 16733675 DOI: 10.1007/s00330-006-0318-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
100 de Jong RGPJ, Peeters PJHL, Burden AM, de Bruin ML, Haak HR, Masclee AAM, de Vries F, Janssen-Heijnen MLG. Gastrointestinal cancer incidence in type 2 diabetes mellitus; results from a large population-based cohort study in the UK. Cancer Epidemiol 2018;54:104-11. [PMID: 29705628 DOI: 10.1016/j.canep.2018.04.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
101 Marqués-Lespier JM, González-Pons M, Cruz-Correa M. Current Perspectives on Gastric Cancer. Gastroenterol Clin North Am 2016;45:413-28. [PMID: 27546840 DOI: 10.1016/j.gtc.2016.04.002] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 11.8] [Reference Citation Analysis]
102 Hongo M. Review article: Barrett’s oesophagus and carcinoma in Japan. Aliment Pharmacol Ther. 2004;20 Suppl 8:50-54. [PMID: 15575874 DOI: 10.1111/j.1365-2036.2004.02230.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 3.5] [Reference Citation Analysis]
103 Cao JQ, Wang GH, Yang WJ, Dai GF, Zhang HF, Xie L, Yu MY, Ye XF. Clinical and pathological characteristics of adenocarcinoma of the esophagogastric junction in Hui and Han patients from Ningxia Hui Autonomous Region: Analysis of 1524 cases. Shijie Huaren Xiaohua Zazhi 2015; 23(12): 1949-1955 [DOI: 10.11569/wcjd.v23.i12.1949] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
104 el-Serag HB. The epidemic of esophageal adenocarcinoma. Gastroenterol Clin North Am. 2002;31:421-440, viii. [PMID: 12134611 DOI: 10.1016/s0889-8553(02)00016-x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
105 Ze-Long Y, Guo-Hui M, Lin Z, Wei-Hong Y, Ke-Cheng Z, Yan-Wen J. Survival Trends of Patients With Surgically Resected Gastric Cardia Cancer From 1988 to 2015: A Population-based Study in the United States. Am J Clin Oncol. 2019;42:581-587. [PMID: 31157623 DOI: 10.1097/coc.0000000000000558] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
106 Ormeci N, Savas B, Coban S, Palabiyikoğlu M, Ensari A, Kuzu I, Kursun N. The usefulness of chromoendoscopy with methylene blue in Barrett's metaplasia and early esophageal carcinoma. Surg Endosc. 2008;22:693-700. [PMID: 17704887 DOI: 10.1007/s00464-007-9463-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
107 Seenan JP, Wirz AA, Robertson EV, Clarke AT, Manning JJ, Kelman AW, Gillen G, Ballantyne S, Derakhshan MH, Mccoll KE. Effect of nitrite delivered in saliva on postprandial gastro-esophageal function. Scandinavian Journal of Gastroenterology 2012;47:387-96. [DOI: 10.3109/00365521.2012.658854] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
108 Schieman C, Wigle DA, Deschamps C, Nichols Iii FC, Cassivi SD, Shen KR, Allen MS. Patterns of operative mortality following esophagectomy: Perioperative death after esophagectomy. Diseases of the Esophagus 2012;25:645-51. [DOI: 10.1111/j.1442-2050.2011.01304.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 6.0] [Reference Citation Analysis]
109 Masclee GM, Coloma PM, de Wilde M, Kuipers EJ, Sturkenboom MC. The incidence of Barrett’s oesophagus and oesophageal adenocarcinoma in the United Kingdom and The Netherlands is levelling off. Aliment Pharmacol Ther. 2014;39:1321-1330. [PMID: 24738722 DOI: 10.1111/apt.12759] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
110 Jenab M, Riboli E, Ferrari P, Friesen M, Sabate J, Norat T, Slimani N, Tjønneland A, Olsen A, Overvad K, Boutron-Ruault MC, Clavel-Chapelon F, Boeing H, Schulz M, Linseisen J, Nagel G, Trichopoulou A, Naska A, Oikonomou E, Berrino F, Panico S, Palli D, Sacerdote C, Tumino R, Peeters PH, Numans ME, Bueno-de-Mesquita HB, Büchner FL, Lund E, Pera G, Chirlaque MD, Sánchez MJ, Arriola L, Barricarte A, Quirós JR, Johansson I, Johansson A, Berglund G, Bingham S, Khaw KT, Allen N, Key T, Carneiro F, Save V, Del Giudice G, Plebani M, Kaaks R, Gonzalez CA. Plasma and dietary carotenoid, retinol and tocopherol levels and the risk of gastric adenocarcinomas in the European prospective investigation into cancer and nutrition. Br J Cancer 2006;95:406-15. [PMID: 16832408 DOI: 10.1038/sj.bjc.6603266] [Cited by in Crossref: 80] [Cited by in F6Publishing: 70] [Article Influence: 5.0] [Reference Citation Analysis]
111 McColl KE, Murray LS, Gillen D, Walker A, Wirz A, Fletcher J, Mowat C, Henry E, Kelman A, Dickson A. Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H pylori testing alone in the management of dyspepsia. BMJ. 2002;324:999-1002. [PMID: 11976239 DOI: 10.1136/bmj.324.7344.999] [Cited by in Crossref: 107] [Cited by in F6Publishing: 92] [Article Influence: 5.4] [Reference Citation Analysis]
112 Cai Z, Zhao JS, Li JJ, Peng DN, Wang XY, Chen TL, Qiu YP, Chen PP, Li WJ, Xu LY, Li EM, Tam JP, Qi RZ, Jia W, Xie D. A combined proteomics and metabolomics profiling of gastric cardia cancer reveals characteristic dysregulations in glucose metabolism. Mol Cell Proteomics. 2010;9:2617-2628. [PMID: 20699381 DOI: 10.1074/mcp.m110.000661] [Cited by in Crossref: 89] [Cited by in F6Publishing: 52] [Article Influence: 7.4] [Reference Citation Analysis]
113 Eom BW, Park JY, Park KB, Yoon HM, Kwon OK, Ryu KW, Kim YW. Comparison of nutrition and quality of life of esophagogastrostomy and the double-tract reconstruction after laparoscopic proximal gastrectomy. Medicine (Baltimore) 2021;100:e25453. [PMID: 33847651 DOI: 10.1097/MD.0000000000025453] [Reference Citation Analysis]
114 Carneiro F, Moutinho C, Pera G, Caldas C, Fenger C, Offerhaus J, Save V, Stenling R, Nesi G, Mahlke U, Bläker H, Torrado J, Roukos DH, Sabourin J, Boeing H, Palli D, Bueno-de-mesquita HB, Overvad K, Bingham S, Clavel-chapelon F, Lund E, Trichopoulou A, Manjer J, Riboli E, Gonzalez CA. Pathology findings and validation of gastric and esophageal cancer cases in a European cohort (EPIC/EUR-GAST). Scandinavian Journal of Gastroenterology 2009;42:618-27. [DOI: 10.1080/00365520601101641] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
115 Roedl JB, Prabhakar HB, Mueller PR, Colen RR, Blake MA. Prediction of Metastatic Disease and Survival in Patients with Gastric and Gastroesophageal Junction Tumors. Academic Radiology 2009;16:218-26. [DOI: 10.1016/j.acra.2008.06.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
116 Shibata A, Matsuda T, Ajiki W, Sobue T. Trend in incidence of adenocarcinoma of the esophagus in Japan, 1993-2001. Jpn J Clin Oncol. 2008;38:464-468. [PMID: 18664481 DOI: 10.1093/jjco/hyn064] [Cited by in Crossref: 78] [Cited by in F6Publishing: 71] [Article Influence: 5.6] [Reference Citation Analysis]
117 Robertson EV, Derakhshan MH, Wirz AA, Mitchell DR, Going JJ, Kelman AW, Ballantyne SA, McColl KEL. Hiatus hernia in healthy volunteers is associated with intrasphincteric reflux and cardiac mucosal lengthening without traditional reflux. Gut 2017;66:1208-15. [PMID: 27196581 DOI: 10.1136/gutjnl-2016-311553] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
118 Øvrebø KK, Aase S, Grong K, Viste A, Svanes K, Sørbye H. Ulceration as a Possible Link between Duodenogastric Reflux and Neoplasms in the Stomach of Rats. Journal of Surgical Research 2002;107:167-78. [DOI: 10.1006/jsre.2002.6501] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
119 Marsman WA, Buskens CJ, Wesseling JG, Offerhaus GJ, Bergman JJ, Tytgat GN, van Lanschot JJ, Bosma PJ. Gene therapy for esophageal carcinoma: the use of an explant model to test adenoviral vectors ex vivo. Cancer Gene Ther 2004;11:289-96. [PMID: 14765131 DOI: 10.1038/sj.cgt.7700680] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
120 Casson AG, Zheng Z, Porter GA, Guernsey DL. Genetic polymorphisms of microsomal epoxide hydroxylase and glutathione S-transferases M1, T1 and P1, interactions with smoking, and risk for esophageal (Barrett) adenocarcinoma. Cancer Detect Prev. 2006;30:423-431. [PMID: 17064856 DOI: 10.1016/j.cdp.2006.09.005] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 2.9] [Reference Citation Analysis]
121 Winter JW, Paterson S, Scobie G, Wirz A, Preston T, McColl KE. N-nitrosamine generation from ingested nitrate via nitric oxide in subjects with and without gastroesophageal reflux. Gastroenterology 2007;133:164-74. [PMID: 17631140 DOI: 10.1053/j.gastro.2007.04.047] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
122 Sinh P, Sharma P. Gastric cardia cancer: how much is it from fat? Dig Dis Sci 2012;57:2493-6. [PMID: 22915196 DOI: 10.1007/s10620-012-2324-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
123 Tinmouth J, Green J, Ko YJ, Liu Y, Paszat L, Sutradhar R, Rabeneck L, Urbach D. A population-based analysis of esophageal and gastric cardia adenocarcinomas in Ontario, Canada: incidence, risk factors, and regional variation. J Gastrointest Surg 2011;15:782-90. [PMID: 21409602 DOI: 10.1007/s11605-011-1450-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
124 Patel SH, Kooby DA. Gastric adenocarcinoma surgery and adjuvant therapy. Surg Clin North Am 2011;91:1039-77. [PMID: 21889029 DOI: 10.1016/j.suc.2011.06.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
125 Powell AGMT, Hughes DL, Brown J, Larsen M, Witherspoon J, Lewis WG. Esophageal cancer's 100 most influential manuscripts: a bibliometric analysis. Diseases of the Esophagus 2017;30:1-8. [DOI: 10.1093/dote/dow039] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
126 Tomaszewski KA, Püsküllüoğlu M, Biesiada K, Bochenek J, Nieckula J, Krzemieniecki K. Validation of the Polish Version of the EORTC QLQ-C30 and the QLQ-OG25 for the Assessment of Health-Related Quality of Life in Patients with Esophagi-Gastric Cancer. Journal of Psychosocial Oncology 2013;31:191-203. [DOI: 10.1080/07347332.2012.761323] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
127 Buergy D, Lohr F, Baack T, Siebenlist K, Haneder S, Michaely H, Wenz F, Boda-Heggemann J. Radiotherapy for tumors of the stomach and gastroesophageal junction--a review of its role in multimodal therapy. Radiat Oncol. 2012;7:192. [PMID: 23157945 DOI: 10.1186/1748-717x-7-192] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
128 Savarino E, Zentilin P, Marabotto E, Bodini G, Della Coletta M, Frazzoni M, de Bortoli N, Martinucci I, Tolone S, Pellegatta G, Savarino V. A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD). Expert Opin Pharmacother. 2017;18:1333-1343. [PMID: 28754071 DOI: 10.1080/14656566.2017.1361407] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
129 Dexter F, Dexter EU, Masursky D, Nussmeier NA. Systematic review of general thoracic surgery articles to identify predictors of operating room case durations. Anesth Analg 2008;106:1232-41, table of contents. [PMID: 18349199 DOI: 10.1213/ane.0b013e318164f0d5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
130 Ge L, Wang HJ, Yin D, Lei C, Zhu JF, Cai XH, Zhang GQ. Effectiveness of 5-flurouracil-based neoadjuvant chemotherapy in locally-advanced gastric/gastroesophageal cancer: A meta-analysis. World J Gastroenterol 2012; 18(48): 7384-7393 [PMID: 23326149 DOI: 10.3748/wjg.v18.i48.7384] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
131 Liu JF, Jiang T, Shi ZH, Liu XB. Prognostic significance of the location of metastatic lymph nodes in patients with adenocarcinoma of the oesophagogastric junction. ANZ J Surg 2018;88:218-22. [PMID: 27444989 DOI: 10.1111/ans.13663] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
132 Keszei AP, Schouten LJ, Driessen AL, Huysentruyt CJ, Keulemans YC, Goldbohm RA, van den Brandt PA. Vegetable, fruit and nitrate intake in relation to the risk of Barrett's oesophagus in a large Dutch cohort. Br J Nutr 2014;111:1452-62. [PMID: 24308274 DOI: 10.1017/S0007114513003929] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
133 Arrington AK, Davydova J, Vickers SM, Yamamoto M. Anti-ERBB2 sh-RNA suppress both cell growth and tumor growth in ERBB2-overexpressing upper gastrointestinal adenocarcinomas. J Gastrointest Surg 2009;13:1754-61. [PMID: 19813066 DOI: 10.1007/s11605-009-0957-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
134 Robertson EV, Derakhshan MH, Wirz AA, Lee YY, Seenan JP, Ballantyne SA, Hanvey SL, Kelman AW, Going JJ, McColl KE. Central obesity in asymptomatic volunteers is associated with increased intrasphincteric acid reflux and lengthening of the cardiac mucosa. Gastroenterology 2013;145:730-9. [PMID: 23796455 DOI: 10.1053/j.gastro.2013.06.038] [Cited by in Crossref: 79] [Cited by in F6Publishing: 54] [Article Influence: 8.8] [Reference Citation Analysis]
135 Beales IL, Vardi I, Dearman L. Regular statin and aspirin use in patients with Barrett’s oesophagus is associated with a reduced incidence of oesophageal adenocarcinoma. Eur J Gastroenterol Hepatol. 2012;24:917-923. [PMID: 22569083 DOI: 10.1097/meg.0b013e3283543f01] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
136 Verschuur EM, Steyerberg EW, Tilanus HW, Polinder S, Essink-Bot ML, Tran KT, van der Gaast A, Stassen LP, Kuipers EJ, Siersema PD. Nurse-led follow-up of patients after oesophageal or gastric cardia cancer surgery: a randomised trial. Br J Cancer. 2009;100:70-76. [PMID: 19066612 DOI: 10.1038/sj.bjc.6604811] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
137 Otterstatter MC, Brierley JD, De P, Ellison LF, Macintyre M, Marrett LD, Semenciw R, Weir HK. Esophageal cancer in Canada: trends according to morphology and anatomical location. Can J Gastroenterol 2012;26:723-7. [PMID: 23061066 DOI: 10.1155/2012/649108] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
138 El-serag HB. The epidemic of esophageal adenocarcinoma. Hematology/Oncology Clinics of North America 2003;17:413-32. [DOI: 10.1016/s0889-8588(03)00020-0] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
139 Doak SH, Jenkins GJ, Parry EM, Griffiths AP, Shah V, Baxter JN, Parry JM. Characterisation of p53 status at the gene, chromosomal and protein levels in oesophageal adenocarcinoma. Br J Cancer. 2003;89:1729-1735. [PMID: 14583777 DOI: 10.1038/sj.bjc.6601323] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
140 Chen MJ, Lee YC, Chiu HM, Wu MS, Wang HP, Lin JT. Time trends of endoscopic and pathological diagnoses related to gastroesophageal reflux disease in a Chinese population: eight years single institution experience. Dis Esophagus. 2010;23:201-207. [PMID: 19788438 DOI: 10.1111/j.1442-2050.2009.01012.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
141 Farhadi A, Fields J, Banan A, Keshavarzian A. Reactive oxygen species: are they involved in the pathogenesis of GERD, Barrett’s esophagus, and the latter’s progression toward esophageal cancer? Am J Gastroenterol. 2002;97:22-26. [PMID: 11808965 DOI: 10.1111/j.1572-0241.2002.05444.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 71] [Article Influence: 3.6] [Reference Citation Analysis]
142 Lepage C, Rachet B, Jooste V, Faivre J, Coleman MP. Continuing Rapid Increase in Esophageal Adenocarcinoma in England and Wales. The American Journal of Gastroenterology 2008;103:2694-9. [DOI: 10.1111/j.1572-0241.2008.02191.x] [Cited by in Crossref: 173] [Cited by in F6Publishing: 268] [Article Influence: 12.4] [Reference Citation Analysis]
143 Balakrishnan M, George R, Sharma A, Graham DY. Changing Trends in Stomach Cancer Throughout the World. Curr Gastroenterol Rep 2017;19:36. [PMID: 28730504 DOI: 10.1007/s11894-017-0575-8] [Cited by in Crossref: 118] [Cited by in F6Publishing: 110] [Article Influence: 23.6] [Reference Citation Analysis]
144 Cai L, Zheng ZL, Zhang ZF. Risk factors for the gastric cardia cancer: A case-control study in Fujian Province. World J Gastroenterol 2003; 9(2): 214-218 [PMID: 12532434 DOI: 10.3748/wjg.v9.i2.214] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 41] [Article Influence: 2.5] [Reference Citation Analysis]
145 McColl KE. Review article: Helicobacter pylori and gastro-oesophageal reflux disease--the European perspective. Aliment Pharmacol Ther. 2004;20 Suppl 8:36-39. [PMID: 15575871 DOI: 10.1111/j.1365-2036.2004.02227.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
146 Wild CP, Hardie LJ. Reflux, Barrett's oesophagus and adenocarcinoma: burning questions. Nat Rev Cancer. 2003;3:676-684. [PMID: 12951586 DOI: 10.1038/nrc1166] [Cited by in Crossref: 189] [Cited by in F6Publishing: 173] [Article Influence: 9.9] [Reference Citation Analysis]
147 Valle JW, Armstrong A, Newman C, Alakhov V, Pietrzynski G, Brewer J, Campbell S, Corrie P, Rowinsky EK, Ranson M. A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction. Invest New Drugs 2011;29:1029-37. [DOI: 10.1007/s10637-010-9399-1] [Cited by in Crossref: 192] [Cited by in F6Publishing: 160] [Article Influence: 16.0] [Reference Citation Analysis]
148 Renouf DJ, Zhai R, Sun B, Xu W, Cheung WY, Heist RS, Kulke MH, Cescon D, Asomaning K, Marshall AL, Li S, Christiani DC, Liu G. Association of MDM2 T309G and p53 Arg72Pro polymorphisms and gastroesophageal reflux disease with survival in esophageal adenocarcinoma. J Gastroenterol Hepatol 2013;28:1482-8. [PMID: 23735059 DOI: 10.1111/jgh.12286] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
149 Koizumi S, Motoyama S, Iijima K. Is the incidence of esophageal adenocarcinoma increasing in Japan? Trends from the data of a hospital-based registration system in Akita Prefecture, Japan. J Gastroenterol 2018;53:827-33. [PMID: 29134330 DOI: 10.1007/s00535-017-1412-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
150 Bosetti C, Levi F, Ferlay J, Garavello W, Lucchini F, Bertuccio P, Negri E, La Vecchia C. Trends in oesophageal cancer incidence and mortality in Europe. Int J Cancer. 2008;122:1118-1129. [PMID: 17990321 DOI: 10.1002/ijc.23232] [Cited by in Crossref: 145] [Cited by in F6Publishing: 259] [Article Influence: 10.4] [Reference Citation Analysis]
151 Vial M, Grande L, Pera M. Epidemiology of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third. Recent Results Cancer Res. 2010;182:1-17. [PMID: 20676867 DOI: 10.1007/978-3-540-70579-6_1] [Cited by in Crossref: 42] [Cited by in F6Publishing: 52] [Article Influence: 3.5] [Reference Citation Analysis]
152 Wallace MB, Nietert PJ, Earle C, Krasna MJ, Hawes RH, Hoffman BJ, Reed CE. An analysis of multiple staging management strategies for carcinoma of the esophagus: computed tomography, endoscopic ultrasound, positron emission tomography, and thoracoscopy/laparoscopy. Ann Thorac Surg. 2002;74:1026-1032. [PMID: 12400740 DOI: 10.1016/s0003-4975(02)03875-4] [Cited by in Crossref: 143] [Cited by in F6Publishing: 35] [Article Influence: 7.2] [Reference Citation Analysis]
153 Zhang S, Guo J, Zhang H, Li H, Hassan MOO, Zhang L. Metastasis pattern and prognosis in men with esophageal cancer patients: A SEER-based study. Medicine (Baltimore) 2021;100:e26496. [PMID: 34160464 DOI: 10.1097/MD.0000000000026496] [Reference Citation Analysis]
154 Lagarde SM, Reitsma JB, de Castro SMM, ten Kate FJW, Busch ORC, van Lanschot JJB. Prognostic nomogram for patients undergoing oesophagectomy for adenocarcinoma of the oesophagus or gastro-oesophageal junction. British Journal of Surgery 2007;94:1361-8. [DOI: 10.1002/bjs.5832] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.5] [Reference Citation Analysis]
155 Keeney S, Bauer TL. Epidemiology of adenocarcinoma of the esophagogastric junction. Surg Oncol Clin N Am. 2006;15:687-696. [PMID: 17030267 DOI: 10.1016/j.soc.2006.07.014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
156 Vizcaino AP, Moreno V, Lambert R, Parkin DM. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. Int J Cancer. 2002;99:860-868. [PMID: 12115489 DOI: 10.1002/ijc.10427] [Cited by in Crossref: 287] [Cited by in F6Publishing: 269] [Article Influence: 14.4] [Reference Citation Analysis]
157 Dempster M, Mccorry NK. The factor structure of the revised Illness Perception Questionnaire in a population of oesophageal cancer survivors: Factor structure of the IPQ-R. Psycho-Oncology 2012;21:524-30. [DOI: 10.1002/pon.1927] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
158 Chao A, Thun MJ, Henley SJ, Jacobs EJ, McCullough ML, Calle EE. Cigarette smoking, use of other tobacco products and stomach cancer mortality in US adults: The Cancer Prevention Study II. Int J Cancer. 2002;101:380-389. [PMID: 12209964 DOI: 10.1002/ijc.10614] [Cited by in Crossref: 92] [Cited by in F6Publishing: 77] [Article Influence: 4.6] [Reference Citation Analysis]
159 Schmassmann A, Oldendorf M, Gebbers J. Changing incidence of gastric and oesophageal cancer subtypes in central Switzerland between 1982 and 2007. Eur J Epidemiol 2009;24:603-9. [DOI: 10.1007/s10654-009-9379-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
160 Forman D. Review article: oesophago-gastric adenocarcinoma -- an epidemiological perspective. Aliment Pharmacol Ther. 2004;20 Suppl 5:55-60; discussion 61-62. [PMID: 15456465 DOI: 10.1111/j.1365-2036.2004.02133.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
161 Xie S, Wang S, Xue L, Middleton DRS, Guan C, Hao C, Wang J, Li B, Chen R, Li X, Wei W. Helicobacter pylori Is Associated With Precancerous and Cancerous Lesions of the Gastric Cardia Mucosa: Results of a Large Population-Based Study in China. Front Oncol 2020;10:205. [PMID: 32195175 DOI: 10.3389/fonc.2020.00205] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
162 Hashibe M, Boffetta P, Janout V, Zaridze D, Shangina O, Mates D, Szeszenia-dabrowska N, Bencko V, Brennan P. Esophageal cancer in Central and Eastern Europe: Tobacco and alcohol. Int J Cancer 2007;120:1518-22. [DOI: 10.1002/ijc.22507] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 3.3] [Reference Citation Analysis]
163 Song M, Kang D, Yang JJ, Choi JY, Sung H, Lee Y, Yoon HS, Choi Y, Kong SH, Lee HJ, Yang HK, Kim WH. Age and sex interactions in gastric cancer incidence and mortality trends in Korea. Gastric Cancer 2015;18:580-9. [PMID: 25091081 DOI: 10.1007/s10120-014-0411-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
164 Kroep S, Lansdorp-vogelaar I, Rubenstein JH, Lemmens VEPP, van Heijningen EB, Aragonés N, van Ballegooijen M, Inadomi JM. Comparing Trends in Esophageal Adenocarcinoma Incidence and Lifestyle Factors Between the United States, Spain, and The Netherlands. American Journal of Gastroenterology 2014;109:336-43. [DOI: 10.1038/ajg.2013.420] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
165 Nemeth IB, Rosztoczy A, Izbeki F, Roka R, Gecse K, Sukosd F, Nyari T, Wittmann T, Tiszlavicz L. A renewed insight into Barrett's esophagus: comparative histopathological analysis of esophageal columnar metaplasia. Dis Esophagus. 2012;25:395-402. [PMID: 22035281 DOI: 10.1111/j.1442-2050.2011.01270.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
166 Maloney JD, Weigel TL. Minimally invasive esophagectomy for malignant and premalignant diseases of the esophagus. Surg Clin North Am 2008;88:979-90, vi. [PMID: 18790149 DOI: 10.1016/j.suc.2008.05.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
167 Navarini D, Gurski RR, Madalosso CA, Aita L, Meurer L, Fornari F. Epidermal growth factor receptor expression in esophageal adenocarcinoma: relationship with tumor stage and survival after esophagectomy. Gastroenterol Res Pract 2012;2012:941954. [PMID: 22792097 DOI: 10.1155/2012/941954] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
168 Iijima K, Shimosegawa T. Involvement of luminal nitric oxide in the pathogenesis of the gastroesophageal reflux disease spectrum: Nitric oxide and esophagus. J Gastroenterol Hepatol 2014;29:898-905. [DOI: 10.1111/jgh.12548] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
169 Jézéquel J, Bessaguet C, Verveur C, Faycal J, Richert Z, Metges JP, Volant A, Nousbaum JB, Robaszkiewicz M. Trends in incidence, management, and survival of gastric and cardia carcinomas in the area of Finistere (France) between 1984 and 2003. Eur J Gastroenterol Hepatol 2010;22:1412-9. [PMID: 21389792 DOI: 10.1097/MEG.0b013e3283408865] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
170 ZeLong Y, ZhenYu C, JianHai L, MingHua Z, KeCheng Z, ChunXi W. Influence of Tumor Location on Lymph Node Metastasis and Survival for Early Gastric Cancer: a Population-Based Study. J Gastrointest Surg 2020;24:1978-86. [PMID: 31463650 DOI: 10.1007/s11605-019-04367-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
171 Genta RM, Pusztaszeri M. The gastric mucosa in gastric cancer patients in a low-incidence area. Eur J Gastroenterol Hepatol 2006;18:1085-93. [PMID: 16957515 DOI: 10.1097/01.meg.0000231753.58211.05] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
172 Taghavi N, Nasrollahzadeh D, Merat S, Yazdanbod A, Hormazdi M, Sotoudeh M, Semnani S, Eslami F, Marjani HA, Fahimi S, Khademi H, Malekzadeh R. Epidemiology of upper gastrointestinal cancers in Iran: A sub site analysis of 761 cases. World J Gastroenterol 2007; 13(40): 5367-5370 [PMID: 17879408 DOI: 10.3748/wjg.v13.i40.5367] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
173 Homs MY, Kuipers EJ, Siersema PD. Palliative therapy. J Surg Oncol. 2005;92:246-256. [PMID: 16299791 DOI: 10.1002/jso.20366] [Cited by in Crossref: 44] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
174 Tinusz B, Szapáry LB, Paládi B, Papp A, Bogner B, Hegedűs I, Bellyei S, Vincze Á, Solt J, Micsik T, Dunás-Varga V, Pályu E, Vass T, Schnabel T, Farkas N, Hegyi P, Thrift AP, Erőss B. The Esophageal Adenocarcinoma Epidemic Has Reached Hungary: A Multicenter, Cross-Sectional Study. Front Oncol 2020;10:541794. [PMID: 33425714 DOI: 10.3389/fonc.2020.541794] [Reference Citation Analysis]
175 Abdi-Rad A, Ghaderi-sohi S, Nadimi-Barfroosh H, Emami S. Trend in incidence of gastric adenocarcinoma by tumor location from 1969-2004: a study in one referral center in Iran. Diagn Pathol 2006;1:5. [PMID: 16759358 DOI: 10.1186/1746-1596-1-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
176 Hiyama T, Yoshihara M, Tanaka S, Chayama K. Genetic polymorphisms and esophageal cancer risk. Int J Cancer. 2007;121:1643-1658. [PMID: 17674367 DOI: 10.1002/ijc.23044] [Cited by in Crossref: 145] [Cited by in F6Publishing: 142] [Article Influence: 9.7] [Reference Citation Analysis]
177 Lepage C, Drouillard A, Jouve JL, Faivre J. Epidemiology and risk factors for oesophageal adenocarcinoma. Dig Liver Dis. 2013;45:625-629. [PMID: 23453359 DOI: 10.1016/j.dld.2012.12.020] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
178 van Duin M, van Marion R, Vissers K, Hop W, Dinjens W, Tilanus H, Siersema P, van Dekken H. High-resolution array comparative genomic hybridization of chromosome 8q: evaluation of putative progression markers for gastroesophageal junction adenocarcinomas. Cytogenet Genome Res 2007;118:130-7. [DOI: 10.1159/000108293] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
179 Voutilainen M. Epidemiological trends in oesophageal cancer in the Nordic countries. Scand J Gastroenterol. 2008;43:323-327. [PMID: 18938769 DOI: 10.1080/17489530701699720] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
180 Phillips WA, Lord RV, Nancarrow DJ, Watson DI, Whiteman DC. Barrett's esophagus. J Gastroenterol Hepatol. 2011;26:639-648. [PMID: 21166712 DOI: 10.1111/j.1440-1746.2010.06602.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 3.7] [Reference Citation Analysis]
181 Lee YC, Cook MB, Bhatia S, Chow WH, El-Omar EM, Goto H, Lin JT, Li YQ, Rhee PL, Sharma P. Interobserver reliability in the endoscopic diagnosis and grading of Barrett’s esophagus: an Asian multinational study. Endoscopy. 2010;42:699-704. [PMID: 20806154 DOI: 10.1055/s-0030-1255629] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
182 Yan YL, Chen X, Liang HJ, Wang J, Li TJ, Li RL, Li S, Qin X. Lack of association between EPHX1 polymorphism and esophageal cancer risk: evidence from meta-analysis. Dis Esophagus 2015;28:164-71. [PMID: 25714851 DOI: 10.1111/dote.12169] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
183 Davelaar AL, Straub D, Buttar NS, Fockens P, Krishnadath KK. Active matrix metalloproteases are expressed early on and are high during the Barrett's esophagus malignancy sequence. Scand J Gastroenterol. 2015;50:321-332. [PMID: 25562781 DOI: 10.3109/00365521.2014.940379] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
184 Siersema PD. Esophageal Cancer. Gastroenterology Clinics of North America 2008;37:943-64. [DOI: 10.1016/j.gtc.2008.09.012] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
185 Langer R, Feith M, Siewert JR, Wester HJ, Hoefler H. Expression and clinical significance of glucose regulated proteins GRP78 (BiP) and GRP94 (GP96) in human adenocarcinomas of the esophagus. BMC Cancer 2008;8:70. [PMID: 18331622 DOI: 10.1186/1471-2407-8-70] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 4.2] [Reference Citation Analysis]
186 Shimoyama S, Yasuda H, Hashimoto M, Tatsutomi Y, Aoki F, Mafune K, Kaminishi M. Accuracy of linear-array EUS for preoperative staging of gastric cardia cancer. Gastrointestinal Endoscopy 2004;60:50-5. [DOI: 10.1016/s0016-5107(04)01312-4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
187 Lagarde SM, ten Kate FJ, Richel DJ, Offerhaus GJ, van Lanschot JJ. Molecular prognostic factors in adenocarcinoma of the esophagus and gastroesophageal junction. Ann Surg Oncol. 2007;14:977-991. [PMID: 17122988 DOI: 10.1245/s10434-006-9262-y] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
188 Feng S, Zheng J, Du X, Tan Y, Yang H, Zhang H, Zhang Z. Human papillomavirus was not detected by PCR using multiple consensus primer sets in esophageal adenocarcinomas in Chinese patients. J Med Virol 2013;85:1053-7. [PMID: 23588731 DOI: 10.1002/jmv.23468] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
189 Huang W, Ren H, Ben Q, Cai Q, Zhu W, Li Z. Risk of esophageal cancer in diabetes mellitus: a meta-analysis of observational studies. Cancer Causes Control 2012;23:263-72. [PMID: 22094992 DOI: 10.1007/s10552-011-9874-9] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 4.4] [Reference Citation Analysis]
190 Shan L, Ying J, Lu N. HER2 expression and relevant clinicopathological features in gastric and gastroesophageal junction adenocarcinoma in a Chinese population. Diagn Pathol. 2013;8:76. [PMID: 23656792 DOI: 10.1186/1746-1596-8-76] [Cited by in Crossref: 38] [Cited by in F6Publishing: 52] [Article Influence: 4.2] [Reference Citation Analysis]
191 Gines A, Cassivi SD, Martenson JA Jr, Schleck C, Deschamps C, Sinicrope FA, Alberts SR, Murray JA, Zinsmeister AR, Vazquez-Sequeiros E, Nichols FC 3rd, Miller RC, Quevedo JF, Allen MS, Alexander JA, Zais T, Haddock MG, Romero Y. Impact of endoscopic ultrasonography and physician specialty on the management of patients with esophagus cancer. Dis Esophagus 2008;21:241-50. [PMID: 18430106 DOI: 10.1111/j.1442-2050.2007.00766.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
192 Buas MF, Vaughan TL. Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease. Semin Radiat Oncol. 2013;23:3-9. [PMID: 23207041 DOI: 10.1016/j.semradonc.2012.09.008] [Cited by in Crossref: 137] [Cited by in F6Publishing: 126] [Article Influence: 15.2] [Reference Citation Analysis]
193 La Vecchia C, Negri E, Lagiou P, Trichopoulos D. Oesophageal adenocarcinoma: A paradigm of mechanical carcinogenesis? Int J Cancer 2002;102:269-70. [DOI: 10.1002/ijc.10697] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
194 Thrumurthy SG, Chaudry MA, Thrumurthy SSD, Mughal M. Oesophageal cancer: risks, prevention, and diagnosis. BMJ. 2019;366:l4373. [PMID: 31289038 DOI: 10.1136/bmj.l4373] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
195 Fitzgerald RC, di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P, Trudgill N, Patel P, Kaye PV, Sanders S, O'Donovan M, Bird-Lieberman E, Bhandari P, Jankowski JA, Attwood S, Parsons SL, Loft D, Lagergren J, Moayyedi P, Lyratzopoulos G, de Caestecker J;  British Society of Gastroenterology. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut. 2014;63:7-42. [PMID: 24165758 DOI: 10.1136/gutjnl-2013-305372] [Cited by in Crossref: 733] [Cited by in F6Publishing: 584] [Article Influence: 81.4] [Reference Citation Analysis]
196 Lunet N, Valbuena C, Vieira AL, Lopes C, Lopes C, David L, Carneiro F, Barros H. Fruit and vegetable consumption and gastric cancer by location and histological type: case-control and meta-analysis. Eur J Cancer Prev. 2007;16:312-327. [PMID: 17554204 DOI: 10.1097/01.cej.0000236255.95769.22] [Cited by in Crossref: 100] [Cited by in F6Publishing: 99] [Article Influence: 6.7] [Reference Citation Analysis]
197 Oze I, Matsuo K, Wakai K, Nagata C, Mizoue T, Tanaka K, Tsuji I, Sasazuki S, Inoue M, Tsugane S. Alcohol drinking and esophageal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol. 2011;41:677-692. [PMID: 21430021 DOI: 10.1093/jjco/hyr026] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 4.2] [Reference Citation Analysis]
198 Cai L, Zheng ZL, Zhang ZF. Cytochrome p450 2E1 polymorphisms and the risk of gastric cardia cancer. World J Gastroenterol 2005; 11(12): 1867-1871 [PMID: 15793883 DOI: 10.3748/wjg.v11.i12.1867] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
199 Gonçalves AR, Carneiro AJ, Martins I, de Faria PA, Ferreira MA, de Mello EL, Fogaça HS, Elia CC, de Souza HS. Prognostic significance of p53 protein expression in early gastric cancer. Pathol Oncol Res 2011;17:349-55. [PMID: 21116760 DOI: 10.1007/s12253-010-9333-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
200 Davelaar AL, Calpe S, Lau L, Timmer MR, Visser M, Ten Kate FJ, Parikh KB, Meijer SL, Bergman JJ, Fockens P, Krishnadath KK. Aberrant TP53 detected by combining immunohistochemistry and DNA-FISH improves Barrett's esophagus progression prediction: A prospective follow-up study. Genes Chromosomes Cancer. 2015;54:82-90. [PMID: 25284618 DOI: 10.1002/gcc.22220] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
201 Bhushan M, Yadav G, Tripathi D, Kumar L, Kishore V, Dewan A, Kumar G, Wahi IK, Gairola M. Dosimetric Analysis of Unflattened (FFFB) and Flattened (FB) Photon Beam Energy for Gastric Cancers Using IMRT and VMAT-a Comparative Study. J Gastrointest Cancer 2019;50:408-19. [PMID: 29520733 DOI: 10.1007/s12029-018-0080-9] [Reference Citation Analysis]
202 Cheng Y, Zhang J, Li Y, Wang Y, Gong J. Proteome analysis of human gastric cardia adenocarcinoma by laser capture microdissection. BMC Cancer. 2007;7:191. [PMID: 17927838 DOI: 10.1186/1471-2407-7-191] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
203 Dempster M, Mccorry NK, Brennan E, Donnelly M, Murray LJ, Johnston BT. Psychological distress among family carers of oesophageal cancer survivors: the role of illness cognitions and coping: Psychological distress in carers of oesophageal cancer survivors. Psycho-Oncology 2011;20:698-705. [DOI: 10.1002/pon.1760] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
204 Yousef F, Cardwell C, Cantwell MM, Galway K, Johnston BT, Murray L. The incidence of esophageal cancer and high-grade dysplasia in Barrett’s esophagus: a systematic review and meta-analysis. Am J Epidemiol. 2008;168:237-249. [PMID: 18550563 DOI: 10.1093/aje/kwn121] [Cited by in Crossref: 273] [Cited by in F6Publishing: 232] [Article Influence: 19.5] [Reference Citation Analysis]
205 van Dekken H, van Marion R, Vissers KJ, Hop WCJ, Dinjens WNM, Tilanus HW, Wink JC, van Duin M. Molecular dissection of the chromosome band 7q21 amplicon in gastroesophageal junction adenocarcinomas identifies cyclin-dependent kinase 6 at both genomic and protein expression levels. Genes Chromosom Cancer 2008;47:649-56. [DOI: 10.1002/gcc.20570] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
206 Jiang DK, Yao L, Wang WZ, Peng B, Ren WH, Yang XM, Yu L. TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: A meta-analysis. World J Gastroenterol 2011; 17(9): 1227-1233 [PMID: 21448430 DOI: 10.3748/wjg.v17.i9.1227] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
207 Kendall C, Stone N, Shepherd N, Geboes K, Warren B, Bennett R, Barr H. Raman spectroscopy, a potential tool for the objective identification and classification of neoplasia in Barrett's oesophagus. J Pathol 2003;200:602-9. [DOI: 10.1002/path.1376] [Cited by in Crossref: 177] [Cited by in F6Publishing: 160] [Article Influence: 9.3] [Reference Citation Analysis]
208 Delaney B, McColl K. Review article: Helicobacter pylori and gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2005;22 Suppl 1:32-40. [PMID: 16042657 DOI: 10.1111/j.1365-2036.2005.02607.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
209 Evans SC, Gillis A, Geldenhuys L, Vaninetti NM, Malatjalian DA, Porter GA, Guernsey DL, Casson AG. Microsatellite instability in esophageal adenocarcinoma. Cancer Lett. 2004;212:241-251. [PMID: 15279904 DOI: 10.1016/j.canlet.2004.03.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
210 Hatta W, Tong D, Lee YY, Ichihara S, Uedo N, Gotoda T. Different time trend and management of esophagogastric junction adenocarcinoma in three Asian countries. Dig Endosc 2017;29 Suppl 2:18-25. [PMID: 28425657 DOI: 10.1111/den.12808] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 5.8] [Reference Citation Analysis]
211 Verschuur EM, Steyerberg EW, Kuipers EJ, Essink-Bot ML, Tran KT, Van Der Gaast A, Tilanus HW, Siersema PD. Experiences and expectations of patients after oesophageal cancer surgery: an explorative study. Eur J Cancer Care (Engl) 2006;15:324-32. [PMID: 16968313 DOI: 10.1111/j.1365-2354.2006.00659.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
212 Brown IS, Whiteman DC, Lauwers GY. Foveolar type dysplasia in Barrett esophagus. Mod Pathol. 2010;23:834-843. [PMID: 20228780 DOI: 10.1038/modpathol.2010.59] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
213 Goh KL. Changing trends in gastrointestinal disease in the Asia-Pacific region. J Dig Dis. 2007;8:179-185. [PMID: 17970873 DOI: 10.1111/j.1751-2980.2007.00304.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
214 Luc G, Durand M, Collet D, Guillemot F, Bordenave L. Esophageal tissue engineering. Expert Rev Med Devices 2014;11:225-41. [PMID: 24387697 DOI: 10.1586/17434440.2014.870470] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
215 McColl KE. When saliva meets acid: chemical warfare at the oesophagogastric junction. Gut. 2005;54:1-3. [PMID: 15591495 DOI: 10.1136/gut.2004.047126] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 4.0] [Reference Citation Analysis]
216 Cesana GC, Romano F, Piacentini G, Scotti M, Brenna A, Bovo G, Vaghi M, Aletti G, Caprotti R, Kaufman H. Low-dose interleukin-2 administered pre-operatively to patients with gastric cancer activates peripheral and peritumoral lymphocytes but does not affect prognosis. Ann Surg Oncol. 2007;14:1295-1304. [PMID: 17225981 DOI: 10.1245/s10434-006-9239-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
217 Akiyama T, Inamori M, Iida H, Mawatari H, Endo H, Hosono K, Yoneda K, Fujita K, Yoneda M, Takahashi H, Goto A, Abe Y, Kobayashi N, Kubota K, Saito S, Nakajima A. Alcohol consumption is associated with an increased risk of erosive esophagitis and Barrett's epithelium in Japanese men. BMC Gastroenterol. 2008;8:58. [PMID: 19077221 DOI: 10.1186/1471-230x-8-58] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
218 Xiong J, Wang Y, Kang W, Ma F, Liu H, Ma S, Li Y, Jin P, Hu H, Tian Y. Prognostic Importance of the Preoperative Naples Prognostic Score for Patients With Adenocarcinoma of the Esophagogastric Junction. Front Oncol 2020;10:595793. [PMID: 33392090 DOI: 10.3389/fonc.2020.595793] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
219 Ege B, Dinç T, Yildiz BD, Balci Z, Bozkaya H. Utility of endoscopy for diagnosis of barrett in a non-Western society: endoscopic and histopathologic correlation. Int Surg 2015;100:720-5. [PMID: 25588717 DOI: 10.9738/INTSURG-D-14-00167.1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
220 Sharma P. Review article: prevalence of Barrett's oesophagus and metaplasia at the gastro-oesophageal junction. Aliment Pharmacol Ther 2004;20 Suppl 5:48-54; discussion 61-2. [PMID: 15456464 DOI: 10.1111/j.1365-2036.2004.02138.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
221 Newnham A, Quinn MJ, Babb P, Kang JY, Majeed A. Trends in oesophageal and gastric cancer incidence, mortality and survival in England and Wales 1971-1998/1999. Aliment Pharmacol Ther. 2003;17:655-664. [PMID: 12641514 DOI: 10.1046/j.1365-2036.2003.01520.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 2.2] [Reference Citation Analysis]
222 Mitra T, Dixit VK, Shukla SK, Yadav DP, Thakur P, Thakur RK. Clinical profile of patients presenting with dysphagia - an experience from a tertiary care center in North India. JGH Open 2020;4:472-6. [PMID: 32514456 DOI: 10.1002/jgh3.12284] [Reference Citation Analysis]
223 Anderson LA, Watson RP, Murphy SJ, Johnston BT, Comber H, Mc Guigan J, Reynolds JV, Murray LJ. Risk factors for Barrett’s oesophagus and oesophageal adenocarcinoma: Results from the FINBAR study. World J Gastroenterol 2007; 13(10): 1585-1594 [PMID: 17461453 DOI: 10.3748/wjg.v13.i10.1585] [Cited by in CrossRef: 184] [Cited by in F6Publishing: 155] [Article Influence: 12.3] [Reference Citation Analysis]
224 Thrift AP, Pandeya N, Whiteman DC. Current status and future perspectives on the etiology of esophageal adenocarcinoma. Front Oncol 2012;2:11. [PMID: 22655259 DOI: 10.3389/fonc.2012.00011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
225 Singh S, Bansal A, Puli S, Wani S, Mathur S, Rastogi A, Sharma P. Effect of Proton Pump Inhibitor Therapy on Inflammatory Changes in the Gastric Cardia (Carditis). Dig Dis Sci 2007;52:2178-82. [DOI: 10.1007/s10620-006-9688-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
226 Falk J, Carstens H, Lundell L, Albertsson M. Incidence of carcinoma of the oesophagus and gastric cardia. Changes over time and geographical differences. Acta Oncologica 2009;46:1070-4. [DOI: 10.1080/02841860701403046] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.0] [Reference Citation Analysis]
227 González CA, Jakszyn P, Pera G, Agudo A, Bingham S, Palli D, Ferrari P, Boeing H, del Giudice G, Plebani M. Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst. 2006;98:345-354. [PMID: 16507831 DOI: 10.1093/jnci/djj071] [Cited by in Crossref: 204] [Cited by in F6Publishing: 176] [Article Influence: 12.8] [Reference Citation Analysis]
228 Olsen CM, Pandeya N, Green AC, Webb PM, Whiteman DC; for the Australian Cancer Study. Population Attributable Fractions of Adenocarcinoma of the Esophagus and Gastroesophageal Junction. American Journal of Epidemiology 2011;174:582-90. [DOI: 10.1093/aje/kwr117] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 3.9] [Reference Citation Analysis]
229 Zamora-ros R, Agudo A, Luján-barroso L, Romieu I, Ferrari P, Knaze V, Bueno-de-mesquita HB, Leenders M, Travis RC, Navarro C, Sánchez-cantalejo E, Slimani N, Scalbert A, Fedirko V, Hjartåker A, Engeset D, Skeie G, Boeing H, Förster J, Li K, Teucher B, Agnoli C, Tumino R, Mattiello A, Saieva C, Johansson I, Stenling R, Redondo ML, Wallström P, Ericson U, Khaw K, Mulligan AA, Trichopoulou A, Dilis V, Katsoulis M, Peeters PH, Igali L, Tjønneland A, Halkjær J, Touillaud M, Perquier F, Fagherazzi G, Amiano P, Ardanaz E, Bredsdorff L, Overvad K, Ricceri F, Riboli E, González CA. Dietary flavonoid and lignan intake and gastric adenocarcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. The American Journal of Clinical Nutrition 2012;96:1398-408. [DOI: 10.3945/ajcn.112.037358] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 6.1] [Reference Citation Analysis]
230 Ychou M, Boige V, Pignon J, Conroy T, Bouché O, Lebreton G, Ducourtieux M, Bedenne L, Fabre J, Saint-aubert B, Genève J, Lasser P, Rougier P. Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial. JCO 2011;29:1715-21. [DOI: 10.1200/jco.2010.33.0597] [Cited by in Crossref: 1046] [Cited by in F6Publishing: 528] [Article Influence: 95.1] [Reference Citation Analysis]
231 Siesling S, van der Aa MA, Coebergh JW, Pukkala E. Time-space trends in cancer incidence in The Netherlands in 1989-2003. Int J Cancer 2008;122:2106-14. [DOI: 10.1002/ijc.23358] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
232 Lehmann K, Schneider PM. Differences in the Molecular Biology of Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third. In: Schneider PM, editor. Adenocarcinoma of the Esophagogastric Junction. Berlin: Springer Berlin Heidelberg; 2010. pp. 65-72. [DOI: 10.1007/978-3-540-70579-6_5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
233 Casson AG, van Lanschot JJB. Improving outcomes after esophagectomy: The impact of operative volume. J Surg Oncol 2005;92:262-6. [DOI: 10.1002/jso.20368] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
234 He Z, Zhao TT, Xu HM, Wang ZN, Xu YY, Song YX, Ni ZR, Xu H, Yin SC, Liu XY, Miao ZF. Efficacy and safety of intraperitoneal chemotherapy in patients with advanced gastric cancer: A cumulative meta-analysis of randomized controlled trials. Oncotarget. 2017;8:81125-81136. [PMID: 29113372 DOI: 10.18632/oncotarget.20818] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
235 Bollschweiler E, Schloesser T, Leers J, Vallböhmer D, Schäfer H, Hölscher AH. High prevalence of colonic polyps in white males with esophageal adenocarcinoma. Dis Colon Rectum. 2009;52:299-304. [PMID: 19279427 DOI: 10.1007/dcr.0b013e318197d06f] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
236 Piazuelo E, Esquivias P, De Martino A, Cebrián C, Conde B, Santander S, Emperador S, García-González MA, Carrera-Lasfuentes P, Lanas A. Acetylsalicylic Acid Exhibits Antitumor Effects in Esophageal Adenocarcinoma Cells In Vitro and In Vivo. Dig Dis Sci 2016;61:2896-907. [PMID: 27343037 DOI: 10.1007/s10620-016-4225-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
237 Rosmolen WD, Nieuwkerk PT, Pouw RE, van Berge Henegouwen MI, Bergman JJ, Sprangers MA. Quality of life and fear of cancer recurrence after endoscopic treatment for early Barrett's neoplasia: a prospective study. Dis Esophagus 2017;30:1-9. [PMID: 27766707 DOI: 10.1111/dote.12512] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
238 Li Y, Sun DL, Duan YN, Zhang XJ, Wang N, Zhou RM, Chen ZF, Wang SJ. Association of functional polymorphisms in MMPs genes with gastric cardia adenocarcinoma and esophageal squamous cell carcinoma in high incidence region of North China. Mol Biol Rep. 2010;37:197-205. [PMID: 19562509 DOI: 10.1007/s11033-009-9593-4] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 3.5] [Reference Citation Analysis]
239 Buckland G, Agudo A, Luján L, Jakszyn P, Bueno-de-Mesquita HB, Palli D, Boeing H, Carneiro F, Krogh V, Sacerdote C. Adherence to a Mediterranean diet and risk of gastric adenocarcinoma within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study. Am J Clin Nutr. 2010;91:381-390. [PMID: 20007304 DOI: 10.3945/ajcn.2009.28209] [Cited by in Crossref: 135] [Cited by in F6Publishing: 115] [Article Influence: 10.4] [Reference Citation Analysis]
240 Zhang Y, Pan T, Zhong X, Cheng C. Nicotine upregulates microRNA-21 and promotes TGF-β-dependent epithelial-mesenchymal transition of esophageal cancer cells. Tumor Biol 2014;35:7063-72. [DOI: 10.1007/s13277-014-1968-z] [Reference Citation Analysis]
241 Toruner M, Soykan I, Ensari A, Kuzu I, Yurdaydin C, Ozden A. Barrett's esophagus: prevalence and its relationship with dyspeptic symptoms. J Gastroenterol Hepatol. 2004;19:535-540. [PMID: 15086597 DOI: 10.1111/j.1440-1746.2003.03342.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 1.9] [Reference Citation Analysis]
242 di Pietro M, Fitzgerald RC. Screening and risk stratification for Barrett’s esophagus: how to limit the clinical impact of the increasing incidence of esophageal adenocarcinoma. Gastroenterol Clin North Am. 2013;42:155-173. [PMID: 23452636 DOI: 10.1016/j.gtc.2012.11.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
243 Cen P, Correa AM, Le JH, Maru D, Anandasabapathy S, Liao Z, Hofstetter WL, Swisher SG, Komaki R, Ross WA, Vaporciyan A, Ajani JA. Adenocarcinoma of the lower esophagus with Barrett's esophagus or without Barrett's esophagus: differences in patients' survival after preoperative chemoradiation. Diseases of the Esophagus 2009;22:32-41. [DOI: 10.1111/j.1442-2050.2008.00881.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
244 Aragonés N, Izarzugaza M, Ramos M, Chirlaque M, Almar E, Martínez C. Trends in oesophago-gastric cancer incidence in Spain: analysis by subsite and histology. Annals of Oncology 2010;21:iii69-75. [DOI: 10.1093/annonc/mdq083] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
245 Choe JW, Kim YC, Joo MK, Kim HJ, Lee BJ, Kim JH, Yeon JE, Park JJ, Kim JS, Byun KS, Bak YT. Application of the Prague C and M criteria for endoscopic description of columnar-lined esophagus in South Korea. World J Gastrointest Endosc 2016; 8(8): 357-361 [PMID: 27114749 DOI: 10.4253/wjge.v8.i8.357] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
246 Casson AG, Williams L, Guernsey DL. Epidemiology and molecular biology of Barrett esophagus. Semin Thorac Cardiovasc Surg. 2005;17:284-291. [PMID: 16428034 DOI: 10.1053/j.semtcvs.2005.09.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
247 Smith KJ, O'Brien SM, Smithers BM, Gotley DC, Webb PM, Green AC, Whiteman DC. Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2005;14:2481-6. [PMID: 16284367 DOI: 10.1158/1055-9965.EPI-05-0370] [Cited by in Crossref: 93] [Cited by in F6Publishing: 48] [Article Influence: 5.8] [Reference Citation Analysis]
248 Liu L, Lu DY, Cai JR, Zhang L. The value of oral contrast ultrasonography in the diagnosis of gastric cancer in elderly patients. World J Surg Oncol 2018;16:233. [PMID: 30526671 DOI: 10.1186/s12957-018-1527-y] [Reference Citation Analysis]
249 Terabe F, Aikou S, Aida J, Yamamichi N, Kaminishi M, Takubo K, Seto Y, Nomura S. Columnar Metaplasia in Three Types of Surgical Mouse Models of Esophageal Reflux. Cell Mol Gastroenterol Hepatol 2017;4:115-23. [PMID: 28593183 DOI: 10.1016/j.jcmgh.2017.03.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
250 Honda M, Wong SL, Healy MA, Nakajima T, Watanabe M, Fukuma S, Fukuhara S, Ayanian JZ. Long-term Trends in Primary Sites of Gastric Adenocarcinoma in Japan and the United States. J Cancer 2017;8:1935-42. [PMID: 28819392 DOI: 10.7150/jca.19174] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
251 Ladanchuk TC, Johnston BT, Murray LJ, Anderson LA. Risk of Barrett’s oesophagus, oesophageal adenocarcinoma and reflux oesophagitis and the use of nitrates and asthma medications. Scand J Gastroenterol. 2010;45:1397-1403. [PMID: 20626305 DOI: 10.3109/00365521.2010.503968] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
252 Qu X, Ben Q, Jiang Y. Consumption of red and processed meat and risk for esophageal squamous cell carcinoma based on a meta-analysis. Ann Epidemiol 2013;23:762-770.e1. [PMID: 24176821 DOI: 10.1016/j.annepidem.2013.09.003] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
253 Brenkman HJF, Ruurda JP, Verhoeven RHA, van Hillegersberg R. Safety and feasibility of minimally invasive gastrectomy during the early introduction in the Netherlands: short-term oncological outcomes comparable to open gastrectomy. Gastric Cancer 2017;20:853-60. [PMID: 28185027 DOI: 10.1007/s10120-017-0695-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
254 Kim JK, Kim GH, Lee BE, Park CH, Jeon HK, Baek DH, Song GA. Endoscopic submucosal dissection for esophagogastric junction tumors: a single-center experience. Surg Endosc 2018;32:760-9. [PMID: 28791503 DOI: 10.1007/s00464-017-5735-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
255 Orditura M, Galizia G, Di Martino N, Ancona E, Castoro C, Pacelli R, Morgillo F, Rossetti S, Gambardella V, Farella A. Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma-a pilot study. Curr Oncol. 2014;21:125-133. [PMID: 24940093 DOI: 10.3747/co.21.1570] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
256 Bornschein J, Selgrad M, Warnecke M, Kuester D, Wex T, Malfertheiner P. H. pylori infection is a key risk factor for proximal gastric cancer. Dig Dis Sci. 2010;55:3124-3131. [PMID: 20668939 DOI: 10.1007/s10620-010-1351-x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 3.9] [Reference Citation Analysis]
257 Carignan CS, Yagi Y. Optical endomicroscopy and the road to real-time, in vivo pathology: present and future. Diagn Pathol 2012;7:98. [PMID: 22889003 DOI: 10.1186/1746-1596-7-98] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
258 Homs MY, Voest EE, Siersema PD. Emerging drugs for esophageal cancer. Expert Opin Emerg Drugs 2009;14:329-39. [PMID: 19453287 DOI: 10.1517/14728210902976842] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
259 Todd JA, de Caestecker J. Surgery or endotherapy for high-grade dysplasia/early adenocarcinoma in Barrett's oesophagus? Eur J Gastroenterol Hepatol 2002;14:1049-51. [PMID: 12362092 DOI: 10.1097/00042737-200210000-00002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
260 Al-Batran SE, Lorenzen S. Management of Locally Advanced Gastroesophageal Cancer: Still a Multidisciplinary Global Challenge? Hematol Oncol Clin North Am 2017;31:441-52. [PMID: 28501086 DOI: 10.1016/j.hoc.2017.01.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
261 Voutilainen M, Sipponen P. Inflammation in the cardia. Curr Gastroenterol Rep 2001;3:215-8. [PMID: 11353557 DOI: 10.1007/s11894-001-0024-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
262 Carrington R, Staffurth J, Warren S, Partridge M, Hurt C, Spezi E, Gwynne S, Hawkins MA, Crosby T. The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: a radiobiological investigation. Radiat Oncol 2015;10:236. [PMID: 26586375 DOI: 10.1186/s13014-015-0537-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
263 Lagarde SM, Ver Loren van Themaat PE, Moerland PD, Gilhuijs-Pederson LA, Ten Kate FJ, Reitsma PH, van Kampen AH, Zwinderman AH, Baas F, van Lanschot JJ. Analysis of gene expression identifies differentially expressed genes and pathways associated with lymphatic dissemination in patients with adenocarcinoma of the esophagus. Ann Surg Oncol. 2008;15:3459-3470. [PMID: 18825457 DOI: 10.1245/s10434-008-0165-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
264 Wang JY, Hsieh JS, Chen CC, Tzou WS, Cheng TL, Chen FM, Huang TJ, Huang YS, Huang SY, Yang T. Alterations of APC, c-met, and p53 genes in tumor tissue and serum of patients with gastric cancers. J Surg Res. 2004;120:242-248. [PMID: 15234219 DOI: 10.1016/j.jss.2003.12.018] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
265 Kim JH, Rhee P, Lee JH, Lee H, Choi YS, Son HJ, Kim JJ, Rhee JC. Prevalence and risk factors of Barrett?s esophagus in Korea. J Gastroenterol Hepatol 2007;22:908-12. [DOI: 10.1111/j.1440-1746.2006.04448.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
266 Subasinghe D, Sivaganesh S, Samarsekera A, Kumarasinghe MP, Samarasekera DN, Lokuhetty MDS. Human Epidermal Growth Factor Receptor-2 in Sri Lankan Gastric Carcinoma Patients with Clinicopathological Association and Survival. Dig Dis Sci 2017;62:2498-510. [PMID: 28612195 DOI: 10.1007/s10620-017-4647-2] [Reference Citation Analysis]
267 Yu X, Chen J, Jiang W, Zhang D. Alcohol, Alcoholic Beverages and Risk of Esophageal Cancer by Histological Type: A Dose–Response Meta-Analysis of Observational Studies. Alcohol and Alcoholism 2020;55:457-67. [DOI: 10.1093/alcalc/agaa047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
268 de Jonge PJ, van Blankenstein M, Grady WM, Kuipers EJ. Barrett's oesophagus: epidemiology, cancer risk and implications for management. Gut. 2014;63:191-202. [PMID: 24092861 DOI: 10.1136/gutjnl-2013-305490] [Cited by in Crossref: 81] [Cited by in F6Publishing: 67] [Article Influence: 9.0] [Reference Citation Analysis]
269 Bakhti SZ, Latifi-Navid S, Zahri S, Bakhti FS, Hajavi N, Yazdanbod A. Are Helicobacter pylori highly cytotoxic genotypes and cardia gastric adenocarcinoma linked? Lessons from Iran. Cancer Biomark. 2017;21:235-246. [PMID: 29036792 DOI: 10.3233/cbm-170701] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
270 Song M, Camargo MC, Katki HA, Weinstein SJ, Männistö S, Albanes D, Surcel HM, Rabkin CS. Association of Antiparietal Cell and Anti-Intrinsic Factor Antibodies With Risk of Gastric Cancer. JAMA Oncol 2021. [PMID: 34913949 DOI: 10.1001/jamaoncol.2021.5395] [Reference Citation Analysis]
271 Crane LM, Schaapveld M, Visser O, Louwman MW, Plukker JT, van Dam GM. Oesophageal cancer in The Netherlands: Increasing incidence and mortality but improving survival. European Journal of Cancer 2007;43:1445-51. [DOI: 10.1016/j.ejca.2007.03.024] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
272 Shimada Y, Watanabe G, Kawamura J, Soma T, Okabe M, Ito T, Inoue H, Kondo M, Mori Y, Tanaka E, Imamura M. Clinical significance of osteopontin in esophageal squamous cell carcinoma: comparison with common tumor markers. Oncology. 2005;68:285-292. [PMID: 16015046 DOI: 10.1159/000086961] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 3.0] [Reference Citation Analysis]
273 Kesting MR, Schurr C, Robitzky L, Steinstraesser L, Nieberler M, Baurecht H, Wolff K, Loeffelbein DJ, Mücke T. Results of Esophagogastroduodenoscopy in Patients With Oral Squamous Cell Carcinoma—Value of Endoscopic Screening: 10-Year Experience. Journal of Oral and Maxillofacial Surgery 2009;67:1649-55. [DOI: 10.1016/j.joms.2009.04.061] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
274 Abrams JA, Gonsalves L, Neugut AI. Diverging trends in the incidence of reflux-related and Helicobacter pylori-related gastric cardia cancer. J Clin Gastroenterol. 2013;47:322-327. [PMID: 22914345 DOI: 10.1097/mcg.0b013e318260177a] [Cited by in Crossref: 28] [Cited by in F6Publishing: 13] [Article Influence: 3.1] [Reference Citation Analysis]
275 Sujendran V, Wheeler J, Baron R, Warren BF, Maynard N. Effect of neoadjuvant chemotherapy on circumferential margin positivity and its impact on prognosis in patients with resectable oesophageal cancer. British Journal of Surgery 2008;95:191-4. [DOI: 10.1002/bjs.5983] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
276 Elsharkawy AA, El-Geidie AA. Self-expanding metal stents in palliation of malignant dysphagia: Outcome of 124 Egyptian patients. Eur Arch Otorhinolaryngol. 2010;267:1123-1127. [PMID: 20069308 DOI: 10.1007/s00405-009-1198-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
277 Chen K, Deng X, Yang Z, Yu D, Zhang X, Zhang J, Xie D, He Z, Cheng D. Survival nomogram for patients with metastatic siewert type II adenocarcinoma of the esophagogastric junction: a population-based study. Expert Rev Gastroenterol Hepatol 2020;14:757-64. [PMID: 32552040 DOI: 10.1080/17474124.2020.1784726] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
278 Polinder S, Verschuur EM, Siersema PD, Kuipers EJ, Steyerberg EW. Cost comparison study of two different follow-up protocols after surgery for oesophageal cancer. Eur J Cancer 2009;45:2110-5. [PMID: 19398325 DOI: 10.1016/j.ejca.2009.03.021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
279 Tomaszewski KA, Püsküllüoğlu M, Biesiada K, Bochenek J, Ochenduszko S, Tomaszewska IM, Krzemieniecki K. Main influencing factors and health-related quality of life issues in patients with oesophago-gastric cancer - as measured by EORTC tools. Contemp Oncol (Pozn) 2013;17:311-6. [PMID: 24596521 DOI: 10.5114/wo.2013.35280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
280 González CA, Pera G, Agudo A, Bueno-de-Mesquita HB, Ceroti M, Boeing H, Schulz M, Del Giudice G, Plebani M, Carneiro F. Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Cancer. 2006;118:2559-2566. [PMID: 16380980 DOI: 10.1002/ijc.21678] [Cited by in Crossref: 213] [Cited by in F6Publishing: 179] [Article Influence: 13.3] [Reference Citation Analysis]
281 Ross WA, Alkassab F, Lynch PM, Ayers GD, Ajani J, Lee JH, Bismar M. Evolving role of self-expanding metal stents in the treatment of malignant dysphagia and fistulas. Gastrointestinal Endoscopy 2007;65:70-6. [DOI: 10.1016/j.gie.2006.04.040] [Cited by in Crossref: 89] [Cited by in F6Publishing: 74] [Article Influence: 5.9] [Reference Citation Analysis]
282 Cook MB, Kamangar F, Whiteman DC, Freedman ND, Gammon MD, Bernstein L, Brown LM, Risch HA, Ye W, Sharp L. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J Natl Cancer Inst. 2010;102:1344-1353. [PMID: 20716718 DOI: 10.1093/jnci/djq289] [Cited by in Crossref: 179] [Cited by in F6Publishing: 161] [Article Influence: 14.9] [Reference Citation Analysis]
283 Donnelly M, Anderson LA, Johnston BT, Watson RG, Murphy SJ, Comber H, McGuigan J, Reynolds JV, Murray LJ. Oesophageal cancer: caregiver mental health and strain. Psychooncology 2008;17:1196-201. [PMID: 18470954 DOI: 10.1002/pon.1337] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
284 Song Q, Hu P, Wang J, Jia Y, Zhang G, Lv L, Liu Y, Cheng Y. Association between gastric cardia adenocarcinoma risk and alcohol flushing response, but not alcohol consumption. Med Oncol 2014;31. [DOI: 10.1007/s12032-014-0858-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
285 Cronin-Fenton DP, Murray LJ, Whiteman DC, Cardwell C, Webb PM, Jordan SJ, Corley DA, Sharp L, Lagergren J. Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis. Eur J Cancer. 2010;46:2067-2076. [PMID: 20456945 DOI: 10.1016/j.ejca.2010.03.032] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 4.9] [Reference Citation Analysis]
286 Farkas K, Szűcs M, Nyári TA. Trends in Gastrointestinal Cancer Mortality Rate in Hungary. Pathol Oncol Res 2016;22:681-8. [PMID: 26965245 DOI: 10.1007/s12253-016-0052-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
287 Matsuzaki J, Suzuki H, Asakura K, Saito Y, Hirata K, Takebayashi T, Hibi T. Gallstones increase the prevalence of Barrett's esophagus. J Gastroenterol 2010;45:171-8. [PMID: 19908109 DOI: 10.1007/s00535-009-0153-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
288 Lin Y, Zheng Y, Wang HL, Wu J. Global Patterns and Trends in Gastric Cancer Incidence Rates (1988-2012) and Predictions to 2030. Gastroenterology 2021;161:116-127.e8. [PMID: 33744306 DOI: 10.1053/j.gastro.2021.03.023] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
289 Vallböhmer D, DeMeester SR, Peters JH, Oh DS, Kuramochi H, Shimizu D, Hagen JA, Danenberg KD, Danenberg PV, DeMeester TR, Chandrasoma PT. Cdx-2 expression in squamous and metaplastic columnar epithelia of the esophagus. Dis Esophagus 2006;19:260-6. [PMID: 16866857 DOI: 10.1111/j.1442-2050.2006.00586.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
290 Jacobson BC, Chan AT, Giovannucci EL, Fuchs CS. Body mass index and Barrett's oesophagus in women. Gut 2009;58:1460-6. [PMID: 19336423 DOI: 10.1136/gut.2008.174508] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
291 Corley DA, Kubo A, Zhao W. Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev. 2008;17:352-358. [PMID: 18268119 DOI: 10.1158/1055-9965.epi-07-0748] [Cited by in Crossref: 148] [Cited by in F6Publishing: 75] [Article Influence: 10.6] [Reference Citation Analysis]
292 Zhang Y, Pan T, Zhong X, Cheng C. Nicotine upregulates microRNA-21 and promotes TGF-β-dependent epithelial-mesenchymal transition of esophageal cancer cells.Tumour Biol. 2014;35:7063-7072. [PMID: 24756761 DOI: 10.1007/s13277-014-1968-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
293 Alcedo J, Ferrández A, Arenas J, Sopeña F, Ortego J, Sainz R, Lanas A. Trends in Barrett's esophagus diagnosis in Southern Europe: implications for surveillance. Dis Esophagus 2009;22:239-48. [PMID: 19425201 DOI: 10.1111/j.1442-2050.2008.00908.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
294 Bornschein J, Quante M, Jansen M. The complexity of cancer origins at the gastro-oesophageal junction. Best Pract Res Clin Gastroenterol 2021;50-51:101729. [PMID: 33975686 DOI: 10.1016/j.bpg.2021.101729] [Reference Citation Analysis]
295 Babar M, Abdel-latif MMM, Ravi N, Murphy A, Byrne PJ, Kelleher D, Reynolds JV. Pilot translational study of dietary vitamin C supplementation in Barrett's esophagus. Diseases of the Esophagus 2010;23:271-6. [DOI: 10.1111/j.1442-2050.2009.01027.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
296 Kresty LA, Clarke J, Ezell K, Exum A, Howell AB, Guettouche T. MicroRNA alterations in Barrett's esophagus, esophageal adenocarcinoma, and esophageal adenocarcinoma cell lines following cranberry extract treatment: Insights for chemoprevention. J Carcinog 2011;10:34. [PMID: 22279419 DOI: 10.4103/1477-3163.91110] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
297 Lorenzen S, Biederstädt A, Ronellenfitsch U, Reißfelder C, Mönig S, Wenz F, Pauligk C, Walker M, Al-Batran SE, Haller B, Hofheinz RD. RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV. BMC Cancer 2020;20:886. [PMID: 32933498 DOI: 10.1186/s12885-020-07388-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
298 Johnson IT. New approaches to the role of diet in the prevention of cancers of the alimentary tract. Mutat Res. 2004;551:9-28. [PMID: 15225578 DOI: 10.1016/j.mrfmmm.2004.02.017] [Cited by in Crossref: 103] [Cited by in F6Publishing: 91] [Article Influence: 5.7] [Reference Citation Analysis]
299 McNamee P, Glendinning S, Shenfine J, Steen N, Griffin SM, Bond J. Chained time trade-off and standard gamble methods. Applications in oesophageal cancer. Eur J Health Econ 2004;5:81-6. [PMID: 15452769 DOI: 10.1007/s10198-003-0217-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
300 Ryun Park S. Management of gastric cancer: East vs west. Current Problems in Cancer 2015;39:315-41. [DOI: 10.1016/j.currproblcancer.2015.10.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
301 Kelly P, Paulin F, Lamont D, Baker L, Clearly S, Exon D, Thompson A. Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer. Br J Cancer. 2012;106:955-961. [PMID: 22294182 DOI: 10.1038/bjc.2012.15] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
302 Al-moundhri MS, Al-bahrani B, Burney IA, Nirmala V, Al-madhani A, Al-nabhani M, Thomas V, Ganguly SS, Grant CS. The clinicopathological features, treatment and survival of gastric adenocarcinoma in Omani Arab patients. Asia-Pacific J Clinical Oncology 2006;2:137-43. [DOI: 10.1111/j.1743-7563.2006.00056.x] [Reference Citation Analysis]
303 Hage M, Siersema PD, Vissers KJ, Steyerberg EW, Haringsma J, Kuipers EJ, van Dekken H. Molecular evaluation of ablative therapy of Barrett's oesophagus. J Pathol 2005;205:57-64. [DOI: 10.1002/path.1685] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
304 Howden CW, Ballard ED, Robieson W. Evidence for Therapeutic Equivalence of Lansoprazole 30mg and Esomeprazole 40mg in the Treatment of Erosive Oesophagitis: . Clinical Drug Investigation 2002;22:99-109. [DOI: 10.2165/00044011-200222020-00004] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
305 Kunzmann AT, Graham S, McShane CM, Doyle J, Tommasino M, Johnston B, Jamison J, James JA, McManus D, Anderson LA. The prevalence of viral agents in esophageal adenocarcinoma and Barrett's esophagus: a systematic review. Eur J Gastroenterol Hepatol. 2017;29:817-825. [PMID: 28252462 DOI: 10.1097/meg.0000000000000868] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 4.3] [Reference Citation Analysis]
306 Lu JB, Sun XB, Dai DX, Zhu SK, Chang QL, Liu SZ, Duan WJ. Epidemiology of gastroenterologic cancer in Henan Province, China. World J Gastroenterol 2003; 9(11): 2400-2403 [PMID: 14606064 DOI: 10.3748/wjg.v9.i11.2400] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 34] [Article Influence: 1.9] [Reference Citation Analysis]
307 Hashemian P, Javid H, Tadayyon Tabrizi A, Hashemy SI. The Role of Tachykinins in the Initiation and Progression of Gastrointestinal Cancers: A Review. Int J Cancer Manag 2020;13. [DOI: 10.5812/ijcm.100717] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
308 Gavin AT, Francisci S, Foschi R, Donnelly DW, Lemmens V, Brenner H, Anderson LA; EUROCARE-4 Working Group. Oesophageal cancer survival in Europe: a EUROCARE-4 study. Cancer Epidemiol. 2012;36:505-512. [PMID: 22910036 DOI: 10.1016/j.canep.2012.07.009] [Cited by in Crossref: 66] [Cited by in F6Publishing: 53] [Article Influence: 6.6] [Reference Citation Analysis]
309 Homs MY, Wahab PJ, Kuipers EJ, Steyerberg EW, Grool TA, Haringsma J, Siersema PD. Esophageal stents with antireflux valve for tumors of the distal esophagus and gastric cardia: a randomized trial. Gastrointest Endosc. 2004;60:695-702. [PMID: 15557944 DOI: 10.1016/s0016-5107(04)02047-4] [Cited by in Crossref: 86] [Cited by in F6Publishing: 16] [Article Influence: 5.1] [Reference Citation Analysis]
310 Orengo MA, Casella C, Fontana V, Filiberti R, Conio M, Rosso S, Tumino R, Crosignani P, De Lisi V, Falcini F. Trends in incidence rates of oesophagus and gastric cancer in Italy by subsite and histology, 1986-1997. Eur J Gastroenterol Hepatol. 2006;18:739-746. [PMID: 16772831 DOI: 10.1097/01.meg.0000223905.78116.38] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
311 Jin L, Yoshida M, Kitagawa Y, Saikawa Y, Takeuchi H, Wada N, Kumai K, Kubota T, Kitajima M. Subclassification of superficial cardia cancer in relation to the endoscopic esophagogastric junction. Journal of Gastroenterology and Hepatology 2008;23:S273-7. [DOI: 10.1111/j.1440-1746.2008.05558.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
312 Jeon J, Luebeck EG, Moolgavkar SH. Age effects and temporal trends in adenocarcinoma of the esophagus and gastric cardia (United States). Cancer Causes Control. 2006;17:971-981. [PMID: 16841264 DOI: 10.1007/s10552-006-0037-3] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
313 Kendall BJ, Macdonald GA, Hayward NK, Prins JB, O’Brien S, Whiteman DC. The risk of Barrett’s esophagus associated with abdominal obesity in males and females. Int J Cancer. 2013;132:2192-2199. [PMID: 23034724 DOI: 10.1002/ijc.27887] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
314 Kubo A, Corley DA. Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol. 2004;99:582-588. [PMID: 15089886 DOI: 10.1111/j.1572-0241.2004.04131.x] [Cited by in Crossref: 113] [Cited by in F6Publishing: 101] [Article Influence: 6.3] [Reference Citation Analysis]
315 Kubo A, Corley DA. Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States. Cancer. 2002;95:2096-2102. [PMID: 12412162 DOI: 10.1002/cncr.10940] [Cited by in Crossref: 79] [Cited by in F6Publishing: 83] [Article Influence: 4.2] [Reference Citation Analysis]
316 Cooper SC, Day R, Brooks C, Livings C, Thomson CS, Trudgill NJ. The influence of deprivation and ethnicity on the incidence of esophageal cancer in England. Cancer Causes Control 2009;20:1459-67. [PMID: 19533393 DOI: 10.1007/s10552-009-9372-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
317 Crane SJ, Richard Locke G, Harmsen WS, Diehl NN, Zinsmeister AR, Joseph Melton L, Romero Y, Talley NJ. The changing incidence of oesophageal and gastric adenocarcinoma by anatomic sub-site. Aliment Pharmacol Ther. 2007;25:447-453. [PMID: 17270000 DOI: 10.1111/j.1365-2036.2006.03229.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
318 Segal F, Breyer HP. Diagnosis and management of Barrett’s metaplasia: What’s new. World J Gastrointest Endosc 2012; 4(9): 379-386 [PMID: 23125895 DOI: 10.4253/wjge.v4.i9.379] [Reference Citation Analysis]
319 Solaymani-Dodaran M, Logan RF, West J, Card T, Coupland C. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Gut. 2004;53:1070-1074. [PMID: 15247170 DOI: 10.1136/gut.2003.028076] [Cited by in Crossref: 185] [Cited by in F6Publishing: 174] [Article Influence: 10.3] [Reference Citation Analysis]
320 Qureshi I, Shende M, Luketich JD. Surgical Palliation for Barrett's Esophagus Cancer. Surgical Oncology Clinics of North America 2009;18:547-60. [DOI: 10.1016/j.soc.2009.03.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
321 Gockel I, Sultanov FS, Domeyer M, Goenner U, Junginger T. Developments in esophageal surgery for adenocarcinoma: a comparison of two decades. BMC Cancer 2007;7:114. [PMID: 17603896 DOI: 10.1186/1471-2407-7-114] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
322 Baguma-Nibasheka M, Barclay C, Li AW, Geldenhuys L, Porter GA, Blay J, Casson AG, Murphy PR. Selective cyclooxygenase-2 inhibition suppresses basic fibroblast growth factor expression in human esophageal adenocarcinoma. Mol Carcinog 2007;46:971-80. [PMID: 17477358 DOI: 10.1002/mc.20339] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
323 Carboni F, Lorusso R, Santoro R, Lepiane P, Mancini P, Sperduti I, Santoro E. Adenocarcinoma of the esophagogastric junction: the role of abdominal-transhiatal resection. Ann Surg Oncol 2009;16:304-10. [PMID: 19050964 DOI: 10.1245/s10434-008-0247-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
324 Van Blankenstein M, Looman CWN, Kruijshaar ME, Siersema PD, Kuipers EJ, Bytzer P. Modelling a population with Barrett's oesophagus from oesophageal adenocarcinoma incidence data. Scandinavian Journal of Gastroenterology 2009;42:308-17. [DOI: 10.1080/00365520600884130] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
325 Chung JW, Lee GH, Choi KS, Kim DH, Jung KW, Song HJ, Choi KD, Jung HY, Kim JH, Yook JH. Unchanging trend of esophagogastric junction adenocarcinoma in Korea: experience at a single institution based on Siewert’s classification. Dis Esophagus. 2009;22:676-681. [PMID: 19222529 DOI: 10.1111/j.1442-2050.2009.00946.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
326 Ovrebø KK, Svanes K, Aase S, Grong K, Kvinnsland S, Sørbye H. Gastric mucosa lesions induced by duodenogastric reflux increase penetration of N-[3H]-methyl-N-nitro-N-nitrosoguanidine into corpus mucosa of rats. Dig Dis Sci 2002;47:2354-69. [PMID: 12395909 DOI: 10.1023/a:1020112016828] [Reference Citation Analysis]
327 Doak SH. Aneuploidy in upper gastro-intestinal tract cancers--a potential prognostic marker? Mutat Res 2008;651:93-104. [PMID: 18093868 DOI: 10.1016/j.mrgentox.2007.10.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
328 Hardie LJ, Darnton SJ, Wallis YL, Chauhan A, Hainaut P, Wild CP, Casson AG. p16 expression in Barrett's esophagus and esophageal adenocarcinoma: association with genetic and epigenetic alterations. Cancer Lett. 2005;217:221-230. [PMID: 15617840 DOI: 10.1016/j.canlet.2004.06.025] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 3.0] [Reference Citation Analysis]
329 Anderson LA, Murray LJ, Murphy SJ, Fitzpatrick DA, Johnston BT, Watson RG, McCarron P, Gavin AT. Mortality in Barrett’s oesophagus: results from a population based study. Gut. 2003;52:1081-1084. [PMID: 12865262 DOI: 10.1136/gut.52.8.1081] [Cited by in Crossref: 106] [Cited by in F6Publishing: 89] [Article Influence: 5.6] [Reference Citation Analysis]
330 Neale JR, James S, Callaghan J, Patel P. Premedication with N-acetylcysteine and simethicone improves mucosal visualization during gastroscopy: a randomized, controlled, endoscopist-blinded study. Eur J Gastroenterol Hepatol. 2013;25:778-783. [PMID: 23739279 DOI: 10.1097/meg.0b013e32836076b2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
331 Song M, Camargo MC, Weinstein SJ, Best AF, Männistö S, Albanes D, Rabkin CS. Family history of cancer in first-degree relatives and risk of gastric cancer and its precursors in a Western population. Gastric Cancer 2018;21:729-37. [PMID: 29455268 DOI: 10.1007/s10120-018-0807-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
332 Aragonés N, Ramis R, Pollán M, Pérez-Gómez B, Gómez-Barroso D, Lope V, Boldo EI, García-Pérez J, López-Abente G. Oesophageal cancer mortality in Spain: a spatial analysis. BMC Cancer 2007;7:3. [PMID: 17201909 DOI: 10.1186/1471-2407-7-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
333 Barzi A, Thara E. Angiogenesis in esophageal and gastric cancer: a paradigm shift in treatment. Expert Opinion on Biological Therapy 2014;14:1319-32. [DOI: 10.1517/14712598.2014.921677] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
334 Desai M, Lieberman DA, Kennedy KF, Hamade N, Thota P, Parasa S, Gorrepati VS, Bansal A, Gupta N, Gaddam S, Young PE, Mathur S, Moawad FJ, Cash BD, Sampliner R, Vargo JJ, Falk GW, Sharma P. Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett's esophagus over the past 2 decades: data from a multicenter U.S. consortium. Gastrointest Endosc 2019;89:257-263.e3. [PMID: 30342028 DOI: 10.1016/j.gie.2018.09.041] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
335 Du X, Hidayat K, Shi BM. Abdominal obesity and gastroesophageal cancer risk: systematic review and meta-analysis of prospective studies. Biosci Rep 2017;37:BSR20160474. [PMID: 28336766 DOI: 10.1042/BSR20160474] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 6.8] [Reference Citation Analysis]
336 Altorki NK, Zhou XK, Stiles B, Port JL, Paul S, Lee PC, Mazumdar M. Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg. 2008;248:221-226. [PMID: 18650631 DOI: 10.1097/sla.0b013e31817bbe59] [Cited by in Crossref: 189] [Cited by in F6Publishing: 69] [Article Influence: 13.5] [Reference Citation Analysis]
337 Mäntynen T, Färkkilä M, Kunnamo I, Mecklin JP, Juhola M, Voutilainen M. The impact of upper GI endoscopy referral volume on the diagnosis of gastroesophageal reflux disease and its complications: a 1-year cross-sectional study in a referral area with 260,000 inhabitants. Am J Gastroenterol. 2002;97:2524-2529. [PMID: 12385433 DOI: 10.1111/j.1572-0241.2002.06034.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
338 Uedo N, Yoshio T, Yoshinaga S, Takeuchi M, Hatta W, Yano T, Tanuma T, Goto O, Takahashi A, Tong D, Lee YY, Nakayama Y, Ichihara S, Gotoda T. Endoscopic gastric mucosal atrophy distinguishes the characteristics of superficial esophagogastric junction adenocarcinoma. Digestive Endoscopy 2017;29:26-36. [DOI: 10.1111/den.12849] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
339 Capellá G, Pera G, Sala N, Agudo A, Rico F, Del Giudicce G, Plebani M, Palli D, Boeing H, Bueno-de-Mesquita HB. DNA repair polymorphisms and the risk of stomach adenocarcinoma and severe chronic gastritis in the EPIC-EURGAST study. Int J Epidemiol. 2008;37:1316-1325. [PMID: 18641418 DOI: 10.1093/ije/dyn145] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 3.6] [Reference Citation Analysis]
340 Lundell L. Re: “DRD2/DARPP-32 Expression Correlates with Lymph Node Metastasis and Tumor Progression in Patients with Esophageal Squamous Cell Carcinoma”. World J Surg 2006;30:1680-1. [DOI: 10.1007/s00268-006-0338-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
341 Pasqual EM, Bertozzi S, Londero AP, Brandolin D, Mariuzzi L, De Pellegrin A, Bacchetti S, Zoratti L, Petri R, Della Bianca C, Snidero D, Terrosu G, Uzzau A, Risaliti A, Di Loreto C, Pizzolitto S, Zilli M, de Manzoni G. Microscopic peritoneal carcinomatosis in gastric cancer: Prevalence, prognosis and predictive factors. Oncol Lett 2018;15:710-6. [PMID: 29399143 DOI: 10.3892/ol.2017.7442] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
342 da Silveira EB, Artifon EL. Cost-Effectiveness of Palliation of Unresectable Esophageal Cancer. Dig Dis Sci 2008;53:3103-11. [DOI: 10.1007/s10620-008-0302-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
343 Newnham A, Quinn MJ, Babb P, Kang JY, Majeed A. Trends in the subsite and morphology of oesophageal and gastric cancer in England and Wales 1971-1998. Aliment Pharmacol Ther. 2003;17:665-676. [PMID: 12641515 DOI: 10.1046/j.1365-2036.2003.01521.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 2.2] [Reference Citation Analysis]
344 Liu C, Russell RM. Nutrition and gastric cancer risk: an update. Nutr Rev. 2008;66:237-249. [PMID: 18454810 DOI: 10.1111/j.1753-4887.2008.00029.x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 75] [Article Influence: 6.1] [Reference Citation Analysis]
345 O'Lorcain P, Deady S, Comber H. Mortality predictions for esophageal, stomach, and pancreatic cancer, Ireland, up to 2015. Int J Gastrointest Cancer 2006;37:15-25. [PMID: 17290077 DOI: 10.1385/IJGC:37:1:15] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
346 Erbil Y, Türkoglu U, Barbaros U, Balik E, Olgac V, Kaya H, Cimşit B. Oxidative damage in an experimentally induced gastric and gastroduodenal reflux model. Surg Innov. 2005;12:219-225. [PMID: 16224642 DOI: 10.1177/155335060501200306] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
347 Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: A combined analysis of 12 case control studies nested within prospective cohorts. Gut. 2001;49:347-353. [PMID: 11511555 DOI: 10.1136/gut.49.3.347] [Cited by in Crossref: 652] [Cited by in F6Publishing: 606] [Article Influence: 31.0] [Reference Citation Analysis]
348 Watanabe S, Hojo M, Nagahara A. Metabolic syndrome and gastrointestinal diseases. J Gastroenterol. 2007;42:267-274. [PMID: 17464454 DOI: 10.1007/s00535-007-2033-0] [Cited by in Crossref: 70] [Cited by in F6Publishing: 60] [Article Influence: 4.7] [Reference Citation Analysis]
349 Kenjo M, Uno T, Murakami Y, Nagata Y, Oguchi M, Saito S, Numasaki H, Teshima T, Mitsumori M. Radiation Therapy for Esophageal Cancer in Japan: Results of the Patterns of Care Study 1999–2001. International Journal of Radiation Oncology*Biology*Physics 2009;75:357-63. [DOI: 10.1016/j.ijrobp.2009.03.073] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
350 Gupta V, Coburn N, Kidane B, Hess KR, Compton C, Ringash J, Darling G, Mahar AL. Survival prediction tools for esophageal and gastroesophageal junction cancer: A systematic review. J Thorac Cardiovasc Surg. 2018;156:847-856. [PMID: 30011772 DOI: 10.1016/j.jtcvs.2018.03.146] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
351 Korswagen LA, Schrama JG, Bruins Slot W, Hunfeld MA. Adenocarcinoma of the lower esophagus after placement of a gastric band. Obes Surg 2009;19:389-92. [PMID: 18841427 DOI: 10.1007/s11695-008-9718-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
352 Cho M, Son T, Kim HI, Noh SH, Choi S, Seo WJ, Roh CK, Hyung WJ. Similar hematologic and nutritional outcomes after proximal gastrectomy with double-tract reconstruction in comparison to total gastrectomy for early upper gastric cancer. Surg Endosc. 2019;33:1757-1768. [PMID: 30203207 DOI: 10.1007/s00464-018-6448-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
353 Baretton GB, Aust DE. [Barrett's esophagus. An update]. Pathologe. 2012;33:5-16. [PMID: 22293785 DOI: 10.1007/s00292-011-1541-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
354 Lagergren J. Etiology and risk factors for oesophageal adenocarcinoma: possibilities for chemoprophylaxis? Best Pract Res Clin Gastroenterol. 2006;20:803-812. [PMID: 16997162 DOI: 10.1016/j.bpg.2006.04.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
355 Wilson BC. Detection and treatment of dysplasia in Barrett's esophagus: a pivotal challenge in translating biophotonics from bench to bedside. J Biomed Opt 2007;12:051401. [PMID: 17994862 DOI: 10.1117/1.2795688] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
356 Peixoto RD, de Sousa TT, Silva PAIA, de Meirelles LR, Teixeira CHA. Complete Response for More than 4 Years following Neoadjuvant FOLFOX and Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for a Patient with Advanced Gastric Cancer with Extensive Peritoneal Carcinomatosis. Case Rep Oncol 2018;11:305-10. [PMID: 29928208 DOI: 10.1159/000488978] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
357 van den Brandt PA, Goldbohm RA. Nutrition in the prevention of gastrointestinal cancer. Best Pract Res Clin Gastroenterol. 2006;20:589-603. [PMID: 16782531 DOI: 10.1016/j.bpg.2006.04.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
358 Suzuki H, Iijima K, Scobie G, Fyfe V, McColl KE. Nitrate and nitrosative chemistry within Barrett’s oesophagus during acid reflux. Gut. 2005;54:1527-1535. [PMID: 16227357 DOI: 10.1136/gut.2005.066043] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 3.8] [Reference Citation Analysis]
359 Romagnuolo J, Scott J, Hawes RH, Hoffman BJ, Reed CE, Aithal GP, Breslin NP, Chen RY, Gumustop B, Hennessey W, Van Velse A, Wallace MB. Helical CT versus EUS with fine needle aspiration for celiac nodal assessment in patients with esophageal cancer. Gastrointest Endosc. 2002;55:648-654. [PMID: 11979245 DOI: 10.1067/mge.2002.122650] [Cited by in Crossref: 76] [Cited by in F6Publishing: 66] [Article Influence: 3.8] [Reference Citation Analysis]
360 Veugelers PJ, Porter GA, Guernsey DL, Casson AG. Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma. Dis Esophagus. 2006;19:321-328. [PMID: 16984526 DOI: 10.1111/j.1442-2050.2006.00602.x] [Cited by in Crossref: 119] [Cited by in F6Publishing: 105] [Article Influence: 7.9] [Reference Citation Analysis]
361 Pera M, Pera M. Recent changes in the epidemiology of esophageal cancer. Surg Oncol 2001;10:81-90. [PMID: 11750227 DOI: 10.1016/s0960-7404(01)00025-1] [Cited by in Crossref: 44] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
362 Lu Y, Lagergren J. Reproductive factors and risk of oesophageal cancer, a population-based nested case-control study in Sweden. Br J Cancer. 2012;107:564-569. [PMID: 22767147 DOI: 10.1038/bjc.2012.285] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
363 Lee YY, Wirz AA, Whiting JG, Robertson EV, Smith D, Weir A, Kelman AW, Derakhshan MH, McColl KE. Waist belt and central obesity cause partial hiatus hernia and short-segment acid reflux in asymptomatic volunteers. Gut 2014;63:1053-60. [PMID: 24064007 DOI: 10.1136/gutjnl-2013-305803] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
364 Schuhmacher C, Reim D, Novotny A. Neoadjuvant treatment for gastric cancer. J Gastric Cancer. 2013;13:73-78. [PMID: 23844320 DOI: 10.5230/jgc.2013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
365 Ding DP, Ma WL, He XF, Zhang Y. XPD Lys751Gln polymorphism and esophageal cancer susceptibility: a meta-analysis of case-control studies. Mol Biol Rep. 2012;39:2533-2540. [PMID: 21667112 DOI: 10.1007/s11033-011-1005-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
366 Pournaghi SJ, Barazandeh Noveyri F, Mohammad Doust H, Ahmadi A, Hamedi A, Rahimi J, Ghasemi M, Hamidi H, Gholamalizadeh M, Doaei S, Lashkardoost H. The Association of Consumption of Animal Proteins and the Risk of Esophageal Cancer. Nutr Cancer 2019;71:1094-9. [PMID: 30955361 DOI: 10.1080/01635581.2019.1597903] [Reference Citation Analysis]
367 Coleman HG, Bhat S, Murray LJ, McManus D, Gavin AT, Johnston BT. Increasing incidence of Barrett’s oesophagus: a population-based study. Eur J Epidemiol. 2011;26:739-745. [PMID: 21671079 DOI: 10.1007/s10654-011-9596-z] [Cited by in Crossref: 76] [Cited by in F6Publishing: 60] [Article Influence: 6.9] [Reference Citation Analysis]
368 Beg MS, Navaneethan U, Atiq M, Komrokji R, Safa M. Outcome of esophageal carcinoma in the veteran affairs population: a comparative analysis from the Veteran Affairs Central Cancer Registry. Am J Clin Oncol 2009;32:286-90. [PMID: 19433959 DOI: 10.1097/COC.0b013e31818af0d8] [Reference Citation Analysis]
369 Coleman HG, Murray LJ, Hicks B, Bhat SK, Kubo A, Corley DA, Cardwell CR, Cantwell MM. Dietary fiber and the risk of precancerous lesions and cancer of the esophagus: a systematic review and meta-analysis. Nutr Rev. 2013;71:474-482. [PMID: 23815145 DOI: 10.1111/nure.12032] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 4.6] [Reference Citation Analysis]
370 Forman D, Burley VJ. Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol. 2006;20:633-649. [PMID: 16997150 DOI: 10.1016/j.bpg.2006.04.008] [Cited by in Crossref: 258] [Cited by in F6Publishing: 247] [Article Influence: 17.2] [Reference Citation Analysis]
371 Fitzsimmons D, Osmond C, George S, Johnson CD. Trends in stomach and pancreatic cancer incidence and mortality in England and Wales, 1951–2000. British Journal of Surgery 2007;94:1162-71. [DOI: 10.1002/bjs.5751] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
372 Merry AH, Schouten LJ, Goldbohm RA, van den Brandt PA. Body mass index, height and risk of adenocarcinoma of the oesophagus and gastric cardia: a prospective cohort study. Gut. 2007;56:1503-1511. [PMID: 17337464 DOI: 10.1136/gut.2006.116665] [Cited by in Crossref: 117] [Cited by in F6Publishing: 109] [Article Influence: 7.8] [Reference Citation Analysis]
373 Li R, Chen T, Hu J, Guo D, Zhang X, Deng D, Li H, Chen X, Tang H. Tumor Volume of Resectable Adenocarcinoma of the Esophagogastric Junction at Multidetector CT: Association with Regional Lymph Node Metastasis and N Stage. Radiology 2013;269:130-8. [DOI: 10.1148/radiol.13122269] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
374 Abdi E, Latifi-Navid S, Zahri S, Yazdanbod A, Safaralizadeh R. Helicobacter pylori genotypes determine risk of non-cardia gastric cancer and intestinal- or diffuse-type GC in Ardabil: A very high-risk area in Northwestern Iran. Microb Pathog. 2017;107:287-292. [PMID: 28390977 DOI: 10.1016/j.micpath.2017.04.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
375 Lepage C, Bouvier A, Manfredi S, Coatmeur O, Cheynel N, Faivre J. Trends in incidence and management of esophageal adenocarcinoma in a well-defined population. Gastroentérologie Clinique et Biologique 2005;29:1258-63. [DOI: 10.1016/s0399-8320(05)82218-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
376 Forman D. Counting cancers at the junction – a problem of routine statistics: . European Journal of Gastroenterology & Hepatology 2002;14:99-101. [DOI: 10.1097/00042737-200202000-00001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
377 González CA, Sala N, Capellá G. Genetic susceptibility and gastric cancer risk. Int J Cancer. 2002;100:249-260. [PMID: 12115538 DOI: 10.1002/ijc.10466] [Cited by in Crossref: 227] [Cited by in F6Publishing: 211] [Article Influence: 11.4] [Reference Citation Analysis]
378 Bertuccio P, Rosato V, Andreano A, Ferraroni M, Decarli A, Edefonti V, La Vecchia C. Dietary patterns and gastric cancer risk: a systematic review and meta-analysis. Ann Oncol. 2013;24:1450-1458. [PMID: 23524862 DOI: 10.1093/annonc/mdt108] [Cited by in Crossref: 97] [Cited by in F6Publishing: 82] [Article Influence: 10.8] [Reference Citation Analysis]
379 Corley DA, Buffler PA. Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents database. Int J Epidemiol. 2001;30:1415-1425. [PMID: 11821356 DOI: 10.1093/ije/30.6.1415] [Cited by in Crossref: 140] [Cited by in F6Publishing: 140] [Article Influence: 7.0] [Reference Citation Analysis]
380 Macfarlane S, Furrie E, Macfarlane GT, Dillon JF. Microbial colonization of the upper gastrointestinal tract in patients with Barrett's esophagus. Clin Infect Dis. 2007;45:29-38. [PMID: 17554697 DOI: 10.1086/518578] [Cited by in Crossref: 101] [Cited by in F6Publishing: 91] [Article Influence: 6.7] [Reference Citation Analysis]
381 Zhang J, Cheng Y. Relationship between Barrett's esophagus and cardia adenocarcinoma. Shijie Huaren Xiaohua Zazhi 2007; 15(25): 2665-2668 [DOI: 10.11569/wcjd.v15.i25.2665] [Cited by in F6Publishing: 1] [Reference Citation Analysis]